{"transactions":[{"id":1012,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":847,"kind":"person","name":"ENRIGHT PATRICK G","position":1,"cik":"0001253886","reported_name":"ENRIGHT PATRICK G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2026-09-02T21:17:08.000Z","date":"2026-08-31","kind":"tax_withholding","planned":false,"acquired":false,"shares":1692,"price":241.39,"value":408431.88,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units."}],"balance_after":21278,"source":{"system":"sec-edgar","filing":"0001253886-26-000011","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1253886/000125388626000011/edgardoc.xml","form_type":"4"}},{"id":1011,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":847,"kind":"person","name":"ENRIGHT PATRICK G","position":1,"cik":"0001253886","reported_name":"ENRIGHT PATRICK G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2026-09-02T21:17:08.000Z","date":"2026-08-31","kind":"tax_withholding","planned":false,"acquired":false,"shares":14,"price":244.6443,"value":3425.0202,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units."}],"balance_after":22970,"source":{"system":"sec-edgar","filing":"0001253886-26-000011","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1253886/000125388626000011/edgardoc.xml","form_type":"4"}},{"id":692942,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":847,"kind":"person","name":"ENRIGHT PATRICK G","position":1,"cik":"0001253886","reported_name":"ENRIGHT PATRICK G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2026-08-07T21:37:03.000Z","date":"2026-08-05","kind":"grant","planned":false,"acquired":true,"shares":1605,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These restricted stock units are granted pursuant to the Issuer's 2007 Amended and Restated Non-Employee Directors Stock Award Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. Subject to the Reporting Person's continuous service and certain additional conditions, these units will vest in full on July 23, 2027."}],"balance_after":22984,"source":{"system":"sec-edgar","filing":"0001253886-26-000008","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000125388626000008/edgardoc.xml","form_type":"4"}},{"id":733640,"issuer":{"id":275,"kind":"organization","name":"Zenas BioPharma, Inc.","symbol":"ZBIO"},"owners":[{"id":847,"kind":"person","name":"ENRIGHT PATRICK G","position":1,"cik":"0001253886","reported_name":"ENRIGHT PATRICK G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-17T22:00:56.000Z","date":"2026-06-15","kind":"grant","planned":false,"acquired":true,"shares":18500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests as to 100% of the underlying shares of common stock on June 15, 2027, the first anniversary of the vesting commencement date, subject to continued service."}],"balance_after":18500,"derivative":{"exercise_price":18.71,"expiration_date":"2036-06-15","underlying":"Common Stock","underlying_shares":18500},"source":{"system":"sec-edgar","filing":"0001104659-26-075251","document":"tm2618042-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1253886/000110465926075251/tm2618042-3_4seq1.xml","form_type":"4"}},{"id":739877,"issuer":{"id":5569,"kind":"organization","name":"BioAge Labs, Inc."},"owners":[{"id":847,"kind":"person","name":"ENRIGHT PATRICK G","position":1,"cik":"0001253886","reported_name":"ENRIGHT PATRICK G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-12T20:33:04.000Z","date":"2026-06-10","kind":"grant","planned":false,"acquired":true,"shares":22000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The entire option award shall vest on the earlier of:  (i) the date of the next annual meeting of the Issuer's stockholders or (ii) the one year anniversary of the grant date, subject to the reporting person's continued service to the Issuer on the applicable vesting date."}],"balance_after":22000,"derivative":{"exercise_price":15.48,"expiration_date":"2036-06-09","underlying":"Common Stock","underlying_shares":22000},"source":{"system":"sec-edgar","filing":"0001253886-26-000006","document":"form4-06122026_080600.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1709941/000125388626000006/form4-06122026_080600.xml","form_type":"4"}},{"id":763434,"issuer":{"id":4358,"kind":"organization","name":"Vera Therapeutics, Inc.","symbol":"VERA"},"owners":[{"id":847,"kind":"person","name":"ENRIGHT PATRICK G","position":1,"cik":"0001253886","reported_name":"ENRIGHT PATRICK G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-05-26T20:15:26.000Z","date":"2026-05-21","kind":"grant","planned":false,"acquired":true,"shares":17084,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest in full on the earlier of the first anniversary of the grant date or the date of the Company's 2027 annual stockholder meeting, subject to the Reporting Person's continuous service through such vesting date. Notwithstanding the foregoing, the shares will vest in full upon a change in control, subject to the Reporting Person's continuous service through the date of such change in control."}],"balance_after":17084,"derivative":{"exercise_price":34.35,"expiration_date":"2036-05-20","underlying":"Class A Common Stock","underlying_shares":17084},"source":{"system":"sec-edgar","filing":"0001253886-26-000004","document":"form4-05262026_080520.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1253886/000125388626000004/form4-05262026_080520.xml","form_type":"4"}},{"id":916139,"issuer":{"id":6966,"kind":"organization","name":"RAPID MICRO BIOSYSTEMS, INC."},"owners":[{"id":67420,"kind":"organization","name":"Longitude Capital Partners II, LLC","position":1,"cik":"0001647491","reported_name":"Longitude Capital Partners II, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67421,"kind":"organization","name":"Longitude Venture Partners II, L.P.","position":2,"cik":"0001527510","reported_name":"Longitude Venture Partners II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67422,"kind":"organization","name":"Longitude Prime Partners, LLC","position":3,"cik":"0001865779","reported_name":"Longitude Prime Partners, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67423,"kind":"organization","name":"Longitude Prime Fund, L.P.","position":4,"cik":"0001865844","reported_name":"Longitude Prime Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":847,"kind":"person","name":"ENRIGHT PATRICK G","position":5,"cik":"0001253886","reported_name":"ENRIGHT PATRICK G","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36915,"kind":"person","name":"Tammenoms Bakker Juliet","position":6,"cik":"0001431159","reported_name":"Tammenoms Bakker Juliet","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2026-02-06T16:26:26.000Z","date":"2026-02-04","kind":"sale","planned":false,"acquired":false,"shares":49000,"price":3.8794,"value":190090.6,"ownership":{"direct":false,"nature":"Held by Longitude Prime Fund, L.P."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The securities are held directly by Longitude Prime Fund, L.P. (\"LPF\"). Longitude Prime Partners, LLC (\"LPP\"), the general partner of LPF, may be deemed to have voting and dispositive power with respect to the shares held by LPF. Mr. Enright and Ms. Tammenoms Bakker are the managing members of LPP and may be deemed to have voting and dispositive power over the shares held by LPF. LPP and each of Mr. Enright and Ms. Tammenoms Bakker disclaim beneficial ownership of such shares except to the extent of their respective pecuniary interests therein."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001193125-26-041248","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1865779/000119312526041248/ownership.xml","form_type":"4"}},{"id":917542,"issuer":{"id":1907,"kind":"organization","name":"Veradermics, Inc","symbol":"MANE"},"owners":[{"id":847,"kind":"person","name":"ENRIGHT PATRICK G","position":1,"cik":"0001253886","reported_name":"ENRIGHT PATRICK G","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-02-06T00:03:06.000Z","date":"2026-02-03","kind":"grant","planned":false,"acquired":true,"shares":45131,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This option shall be fully vested and exercisable on February 3, 2027, the first anniversary of the vesting commencement date."}],"balance_after":45131,"derivative":{"exercise_price":17,"expiration_date":"2036-02-03","underlying":"Common Stock","underlying_shares":45131},"source":{"system":"sec-edgar","filing":"0001628280-26-005904","document":"wk-form4_1770336183.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1253886/000162828026005904/wk-form4_1770336183.xml","form_type":"4"}},{"id":917541,"issuer":{"id":1907,"kind":"organization","name":"Veradermics, Inc","symbol":"MANE"},"owners":[{"id":847,"kind":"person","name":"ENRIGHT PATRICK G","position":1,"cik":"0001253886","reported_name":"ENRIGHT PATRICK G","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series C Convertible Preferred Stock","published_at":"2026-02-06T00:03:06.000Z","date":"2026-02-05","kind":"exercise","planned":false,"acquired":false,"shares":1171121,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"On February 5, 2026, the shares of Series C Convertible Preferred Stock automatically converted into shares of Common Stock on a on a 10.067-for-1 basis without payment of further consideration immediately prior to the closing of the Issuer's initial public offering. The shares have no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"On February 5, 2026, the shares of Series C Convertible Preferred Stock automatically converted into shares of Common Stock on a on a 10.067-for-1 basis without payment of further consideration immediately prior to the closing of the Issuer's initial public offering. The shares have no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On February 5, 2026, the shares of Series C Convertible Preferred Stock automatically converted into shares of Common Stock on a on a 10.067-for-1 basis without payment of further consideration immediately prior to the closing of the Issuer's initial public offering. The shares have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On February 5, 2026, the shares of Series C Convertible Preferred Stock automatically converted into shares of Common Stock on a on a 10.067-for-1 basis without payment of further consideration immediately prior to the closing of the Issuer's initial public offering. The shares have no expiration date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1171121},"source":{"system":"sec-edgar","filing":"0001628280-26-005904","document":"wk-form4_1770336183.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1253886/000162828026005904/wk-form4_1770336183.xml","form_type":"4"}},{"id":917540,"issuer":{"id":1907,"kind":"organization","name":"Veradermics, Inc","symbol":"MANE"},"owners":[{"id":847,"kind":"person","name":"ENRIGHT PATRICK G","position":1,"cik":"0001253886","reported_name":"ENRIGHT PATRICK G","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series C Convertible Preferred Stock","published_at":"2026-02-06T00:03:06.000Z","date":"2026-02-05","kind":"exercise","planned":false,"acquired":false,"shares":1171121,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"On February 5, 2026, the shares of Series C Convertible Preferred Stock automatically converted into shares of Common Stock on a on a 10.067-for-1 basis without payment of further consideration immediately prior to the closing of the Issuer's initial public offering. The shares have no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"On February 5, 2026, the shares of Series C Convertible Preferred Stock automatically converted into shares of Common Stock on a on a 10.067-for-1 basis without payment of further consideration immediately prior to the closing of the Issuer's initial public offering. The shares have no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On February 5, 2026, the shares of Series C Convertible Preferred Stock automatically converted into shares of Common Stock on a on a 10.067-for-1 basis without payment of further consideration immediately prior to the closing of the Issuer's initial public offering. The shares have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On February 5, 2026, the shares of Series C Convertible Preferred Stock automatically converted into shares of Common Stock on a on a 10.067-for-1 basis without payment of further consideration immediately prior to the closing of the Issuer's initial public offering. The shares have no expiration date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1171121},"source":{"system":"sec-edgar","filing":"0001628280-26-005904","document":"wk-form4_1770336183.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1253886/000162828026005904/wk-form4_1770336183.xml","form_type":"4"}},{"id":917539,"issuer":{"id":1907,"kind":"organization","name":"Veradermics, Inc","symbol":"MANE"},"owners":[{"id":847,"kind":"person","name":"ENRIGHT PATRICK G","position":1,"cik":"0001253886","reported_name":"ENRIGHT PATRICK G","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B Convertible Preferred Stock","published_at":"2026-02-06T00:03:06.000Z","date":"2026-02-05","kind":"exercise","planned":false,"acquired":false,"shares":1236631,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"On February 5, 2026, the shares of Series B Convertible Preferred Stock automatically converted into shares of the Issuer's common stock, par value $0.00001 per share (\"Common Stock\"), on a 10.067-for-1 basis without payment of further consideration immediately prior to the closing of the Issuer's initial public offering. The shares have no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On February 5, 2026, the shares of Series B Convertible Preferred Stock automatically converted into shares of the Issuer's common stock, par value $0.00001 per share (\"Common Stock\"), on a 10.067-for-1 basis without payment of further consideration immediately prior to the closing of the Issuer's initial public offering. The shares have no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On February 5, 2026, the shares of Series B Convertible Preferred Stock automatically converted into shares of the Issuer's common stock, par value $0.00001 per share (\"Common Stock\"), on a 10.067-for-1 basis without payment of further consideration immediately prior to the closing of the Issuer's initial public offering. The shares have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On February 5, 2026, the shares of Series B Convertible Preferred Stock automatically converted into shares of the Issuer's common stock, par value $0.00001 per share (\"Common Stock\"), on a 10.067-for-1 basis without payment of further consideration immediately prior to the closing of the Issuer's initial public offering. The shares have no expiration date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1236631},"source":{"system":"sec-edgar","filing":"0001628280-26-005904","document":"wk-form4_1770336183.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1253886/000162828026005904/wk-form4_1770336183.xml","form_type":"4"}},{"id":917538,"issuer":{"id":1907,"kind":"organization","name":"Veradermics, Inc","symbol":"MANE"},"owners":[{"id":847,"kind":"person","name":"ENRIGHT PATRICK G","position":1,"cik":"0001253886","reported_name":"ENRIGHT PATRICK G","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-02-06T00:03:06.000Z","date":"2026-02-05","kind":"purchase","planned":false,"acquired":true,"shares":882353,"price":17,"value":15000001.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"These shares are held by Longitude 103.8 East, L.P. (\"L103\"). Longitude 103.8 East Partners, LLC (\"L103P\") is the general partner of L103 and may be deemed to have voting, investment and dispositive power with respect to these shares. Juliet Tammenoms Bakker and the Reporting Person, a member of the board of directors of the Issuer, are the managing members of L103P, and may each be deemed to share voting, investment and dispositive power with respect to these shares. Each of L103P, Ms. Tammenoms Bakker and the Reporting Person disclaims beneficial ownership of such shares except to the extent of their respective pecuniary interests therein."}],"balance_after":2053474,"source":{"system":"sec-edgar","filing":"0001628280-26-005904","document":"wk-form4_1770336183.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1253886/000162828026005904/wk-form4_1770336183.xml","form_type":"4"}},{"id":917537,"issuer":{"id":1907,"kind":"organization","name":"Veradermics, Inc","symbol":"MANE"},"owners":[{"id":847,"kind":"person","name":"ENRIGHT PATRICK G","position":1,"cik":"0001253886","reported_name":"ENRIGHT PATRICK G","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-02-06T00:03:06.000Z","date":"2026-02-05","kind":"purchase","planned":false,"acquired":true,"shares":192647,"price":17,"value":3274999.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held by Longitude Venture Partners V, L.P. (\"LVPV\"). Longitude Capital Partners V, LLC (\"LCPV\"), is the general partner of LVPV and may be deemed to have voting, investment and dispositive power with respect to these shares. Juliet Tammenoms Bakker and the Reporting Person, a member of the board of directors of the Issuer, are the managing members of LCPV, and may each be deemed to share voting, investment and dispositive power with respect to these shares. Each of LCPV, Ms. Tammenoms Bakker and the Reporting Person disclaims beneficial ownership of such shares except to the extent of their respective pecuniary interests therein."}],"balance_after":2600399,"source":{"system":"sec-edgar","filing":"0001628280-26-005904","document":"wk-form4_1770336183.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1253886/000162828026005904/wk-form4_1770336183.xml","form_type":"4"}},{"id":917536,"issuer":{"id":1907,"kind":"organization","name":"Veradermics, Inc","symbol":"MANE"},"owners":[{"id":847,"kind":"person","name":"ENRIGHT PATRICK G","position":1,"cik":"0001253886","reported_name":"ENRIGHT PATRICK G","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-02-06T00:03:06.000Z","date":"2026-02-05","kind":"exercise","planned":false,"acquired":true,"shares":1171121,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"On February 5, 2026, the shares of Series C Convertible Preferred Stock automatically converted into shares of Common Stock on a on a 10.067-for-1 basis without payment of further consideration immediately prior to the closing of the Issuer's initial public offering. The shares have no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"On February 5, 2026, the shares of Series C Convertible Preferred Stock automatically converted into shares of Common Stock on a on a 10.067-for-1 basis without payment of further consideration immediately prior to the closing of the Issuer's initial public offering. The shares have no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"These shares are held by Longitude 103.8 East, L.P. (\"L103\"). Longitude 103.8 East Partners, LLC (\"L103P\") is the general partner of L103 and may be deemed to have voting, investment and dispositive power with respect to these shares. Juliet Tammenoms Bakker and the Reporting Person, a member of the board of directors of the Issuer, are the managing members of L103P, and may each be deemed to share voting, investment and dispositive power with respect to these shares. Each of L103P, Ms. Tammenoms Bakker and the Reporting Person disclaims beneficial ownership of such shares except to the extent of their respective pecuniary interests therein."}],"balance_after":1171121,"source":{"system":"sec-edgar","filing":"0001628280-26-005904","document":"wk-form4_1770336183.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1253886/000162828026005904/wk-form4_1770336183.xml","form_type":"4"}},{"id":917535,"issuer":{"id":1907,"kind":"organization","name":"Veradermics, Inc","symbol":"MANE"},"owners":[{"id":847,"kind":"person","name":"ENRIGHT PATRICK G","position":1,"cik":"0001253886","reported_name":"ENRIGHT PATRICK G","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-02-06T00:03:06.000Z","date":"2026-02-05","kind":"exercise","planned":false,"acquired":true,"shares":1171121,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"On February 5, 2026, the shares of Series C Convertible Preferred Stock automatically converted into shares of Common Stock on a on a 10.067-for-1 basis without payment of further consideration immediately prior to the closing of the Issuer's initial public offering. The shares have no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"On February 5, 2026, the shares of Series C Convertible Preferred Stock automatically converted into shares of Common Stock on a on a 10.067-for-1 basis without payment of further consideration immediately prior to the closing of the Issuer's initial public offering. The shares have no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held by Longitude Venture Partners V, L.P. (\"LVPV\"). Longitude Capital Partners V, LLC (\"LCPV\"), is the general partner of LVPV and may be deemed to have voting, investment and dispositive power with respect to these shares. Juliet Tammenoms Bakker and the Reporting Person, a member of the board of directors of the Issuer, are the managing members of LCPV, and may each be deemed to share voting, investment and dispositive power with respect to these shares. Each of LCPV, Ms. Tammenoms Bakker and the Reporting Person disclaims beneficial ownership of such shares except to the extent of their respective pecuniary interests therein."}],"balance_after":2407752,"source":{"system":"sec-edgar","filing":"0001628280-26-005904","document":"wk-form4_1770336183.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1253886/000162828026005904/wk-form4_1770336183.xml","form_type":"4"}},{"id":917534,"issuer":{"id":1907,"kind":"organization","name":"Veradermics, Inc","symbol":"MANE"},"owners":[{"id":847,"kind":"person","name":"ENRIGHT PATRICK G","position":1,"cik":"0001253886","reported_name":"ENRIGHT PATRICK G","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-02-06T00:03:06.000Z","date":"2026-02-05","kind":"exercise","planned":false,"acquired":true,"shares":1236631,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On February 5, 2026, the shares of Series B Convertible Preferred Stock automatically converted into shares of the Issuer's common stock, par value $0.00001 per share (\"Common Stock\"), on a 10.067-for-1 basis without payment of further consideration immediately prior to the closing of the Issuer's initial public offering. The shares have no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On February 5, 2026, the shares of Series B Convertible Preferred Stock automatically converted into shares of the Issuer's common stock, par value $0.00001 per share (\"Common Stock\"), on a 10.067-for-1 basis without payment of further consideration immediately prior to the closing of the Issuer's initial public offering. The shares have no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held by Longitude Venture Partners V, L.P. (\"LVPV\"). Longitude Capital Partners V, LLC (\"LCPV\"), is the general partner of LVPV and may be deemed to have voting, investment and dispositive power with respect to these shares. Juliet Tammenoms Bakker and the Reporting Person, a member of the board of directors of the Issuer, are the managing members of LCPV, and may each be deemed to share voting, investment and dispositive power with respect to these shares. Each of LCPV, Ms. Tammenoms Bakker and the Reporting Person disclaims beneficial ownership of such shares except to the extent of their respective pecuniary interests therein."}],"balance_after":1236631,"source":{"system":"sec-edgar","filing":"0001628280-26-005904","document":"wk-form4_1770336183.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1253886/000162828026005904/wk-form4_1770336183.xml","form_type":"4"}},{"id":922144,"issuer":{"id":6966,"kind":"organization","name":"RAPID MICRO BIOSYSTEMS, INC."},"owners":[{"id":67420,"kind":"organization","name":"Longitude Capital Partners II, LLC","position":1,"cik":"0001647491","reported_name":"Longitude Capital Partners II, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67421,"kind":"organization","name":"Longitude Venture Partners II, L.P.","position":2,"cik":"0001527510","reported_name":"Longitude Venture Partners II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67422,"kind":"organization","name":"Longitude Prime Partners, LLC","position":3,"cik":"0001865779","reported_name":"Longitude Prime Partners, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":847,"kind":"person","name":"ENRIGHT PATRICK G","position":4,"cik":"0001253886","reported_name":"ENRIGHT PATRICK G","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36915,"kind":"person","name":"Tammenoms Bakker Juliet","position":5,"cik":"0001431159","reported_name":"Tammenoms Bakker Juliet","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2026-02-03T20:50:11.000Z","date":"2026-01-23","kind":"other","planned":false,"acquired":false,"shares":129032,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Held by Longitude Venture Partners II, L.P."},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The warrant is immediately exercisable."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities are held directly by LVPII. Longitude Capital Partners II, LLC, (\"LCPII\"), the general partner of LVPII, may be deemed to have voting and dispositive power with respect to the shares held by LVPII. Patrick G. Enright and Juliet Tammenoms Bakker are the managing members of LCPII and may be deemed to share voting and dispositive power over the shares held by LVPII. Each of LCPII, Mr. Enright and Ms. Tammenoms Bakker disclaim beneficial ownership of such securities and this report shall not be deemed an admission that any one of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interest therein."}],"balance_after":0,"derivative":{"exercise_price":0.05,"expiration_date":"2028-01-17","underlying":"Class A Common Stock","underlying_shares":129032},"source":{"system":"sec-edgar","filing":"0001193125-26-036387","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1865779/000119312526036387/ownership.xml","form_type":"4"}},{"id":922143,"issuer":{"id":6966,"kind":"organization","name":"RAPID MICRO BIOSYSTEMS, INC."},"owners":[{"id":67420,"kind":"organization","name":"Longitude Capital Partners II, LLC","position":1,"cik":"0001647491","reported_name":"Longitude Capital Partners II, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67421,"kind":"organization","name":"Longitude Venture Partners II, L.P.","position":2,"cik":"0001527510","reported_name":"Longitude Venture Partners II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67422,"kind":"organization","name":"Longitude Prime Partners, LLC","position":3,"cik":"0001865779","reported_name":"Longitude Prime Partners, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":847,"kind":"person","name":"ENRIGHT PATRICK G","position":4,"cik":"0001253886","reported_name":"ENRIGHT PATRICK G","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36915,"kind":"person","name":"Tammenoms Bakker Juliet","position":5,"cik":"0001431159","reported_name":"Tammenoms Bakker Juliet","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2026-02-03T20:50:11.000Z","date":"2026-01-23","kind":"other","planned":false,"acquired":false,"shares":500000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Held by Longitude Venture Partners II, L.P."},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The warrant is immediately exercisable."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities are held directly by LVPII. Longitude Capital Partners II, LLC, (\"LCPII\"), the general partner of LVPII, may be deemed to have voting and dispositive power with respect to the shares held by LVPII. Patrick G. Enright and Juliet Tammenoms Bakker are the managing members of LCPII and may be deemed to share voting and dispositive power over the shares held by LVPII. Each of LCPII, Mr. Enright and Ms. Tammenoms Bakker disclaim beneficial ownership of such securities and this report shall not be deemed an admission that any one of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interest therein."}],"balance_after":0,"derivative":{"exercise_price":0.05,"expiration_date":"2027-07-24","underlying":"Class A Common Stock","underlying_shares":500000},"source":{"system":"sec-edgar","filing":"0001193125-26-036387","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1865779/000119312526036387/ownership.xml","form_type":"4"}},{"id":922142,"issuer":{"id":6966,"kind":"organization","name":"RAPID MICRO BIOSYSTEMS, INC."},"owners":[{"id":67420,"kind":"organization","name":"Longitude Capital Partners II, LLC","position":1,"cik":"0001647491","reported_name":"Longitude Capital Partners II, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67421,"kind":"organization","name":"Longitude Venture Partners II, L.P.","position":2,"cik":"0001527510","reported_name":"Longitude Venture Partners II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67422,"kind":"organization","name":"Longitude Prime Partners, LLC","position":3,"cik":"0001865779","reported_name":"Longitude Prime Partners, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":847,"kind":"person","name":"ENRIGHT PATRICK G","position":4,"cik":"0001253886","reported_name":"ENRIGHT PATRICK G","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36915,"kind":"person","name":"Tammenoms Bakker Juliet","position":5,"cik":"0001431159","reported_name":"Tammenoms Bakker Juliet","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2026-02-03T20:50:11.000Z","date":"2026-02-03","kind":"sale","planned":false,"acquired":false,"shares":27500,"price":4.2415,"value":116641.25,"ownership":{"direct":false,"nature":"Held by Longitude Prime Fund, L.P."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The securities are held directly by Longitude Prime Fund, L.P. (\"LPF\"). Longitude Prime Partners, LLC (\"LPP\"), the general partner of LPF, may be deemed to have voting and dispositive power with respect to the shares held by LPF. Mr. Enright and Ms. Tammenoms Bakker are the managing members of LPP and may be deemed to have voting and dispositive power over the shares held by LPF. LPP and each of Mr. Enright and Ms. Tammenoms Bakker disclaim beneficial ownership of such shares except to the extent of their respective pecuniary interests therein."}],"balance_after":49000,"source":{"system":"sec-edgar","filing":"0001193125-26-036387","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1865779/000119312526036387/ownership.xml","form_type":"4"}},{"id":922141,"issuer":{"id":6966,"kind":"organization","name":"RAPID MICRO BIOSYSTEMS, INC."},"owners":[{"id":67420,"kind":"organization","name":"Longitude Capital Partners II, LLC","position":1,"cik":"0001647491","reported_name":"Longitude Capital Partners II, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67421,"kind":"organization","name":"Longitude Venture Partners II, L.P.","position":2,"cik":"0001527510","reported_name":"Longitude Venture Partners II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67422,"kind":"organization","name":"Longitude Prime Partners, LLC","position":3,"cik":"0001865779","reported_name":"Longitude Prime Partners, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":847,"kind":"person","name":"ENRIGHT PATRICK G","position":4,"cik":"0001253886","reported_name":"ENRIGHT PATRICK G","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36915,"kind":"person","name":"Tammenoms Bakker Juliet","position":5,"cik":"0001431159","reported_name":"Tammenoms Bakker Juliet","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2026-02-03T20:50:11.000Z","date":"2026-02-02","kind":"sale","planned":false,"acquired":false,"shares":27500,"price":4.246,"value":116765.0,"ownership":{"direct":false,"nature":"Held by Longitude Prime Fund, L.P."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The securities are held directly by Longitude Prime Fund, L.P. (\"LPF\"). Longitude Prime Partners, LLC (\"LPP\"), the general partner of LPF, may be deemed to have voting and dispositive power with respect to the shares held by LPF. Mr. Enright and Ms. Tammenoms Bakker are the managing members of LPP and may be deemed to have voting and dispositive power over the shares held by LPF. LPP and each of Mr. Enright and Ms. Tammenoms Bakker disclaim beneficial ownership of such shares except to the extent of their respective pecuniary interests therein."}],"balance_after":76500,"source":{"system":"sec-edgar","filing":"0001193125-26-036387","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1865779/000119312526036387/ownership.xml","form_type":"4"}},{"id":922140,"issuer":{"id":6966,"kind":"organization","name":"RAPID MICRO BIOSYSTEMS, INC."},"owners":[{"id":67420,"kind":"organization","name":"Longitude Capital Partners II, LLC","position":1,"cik":"0001647491","reported_name":"Longitude Capital Partners II, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67421,"kind":"organization","name":"Longitude Venture Partners II, L.P.","position":2,"cik":"0001527510","reported_name":"Longitude Venture Partners II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67422,"kind":"organization","name":"Longitude Prime Partners, LLC","position":3,"cik":"0001865779","reported_name":"Longitude Prime Partners, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":847,"kind":"person","name":"ENRIGHT PATRICK G","position":4,"cik":"0001253886","reported_name":"ENRIGHT PATRICK G","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36915,"kind":"person","name":"Tammenoms Bakker Juliet","position":5,"cik":"0001431159","reported_name":"Tammenoms Bakker Juliet","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2026-02-03T20:50:11.000Z","date":"2026-01-30","kind":"sale","planned":false,"acquired":false,"shares":46000,"price":4.5435,"value":209001.0,"ownership":{"direct":false,"nature":"Held by Longitude Prime Fund, L.P."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The securities are held directly by Longitude Prime Fund, L.P. (\"LPF\"). Longitude Prime Partners, LLC (\"LPP\"), the general partner of LPF, may be deemed to have voting and dispositive power with respect to the shares held by LPF. Mr. Enright and Ms. Tammenoms Bakker are the managing members of LPP and may be deemed to have voting and dispositive power over the shares held by LPF. LPP and each of Mr. Enright and Ms. Tammenoms Bakker disclaim beneficial ownership of such shares except to the extent of their respective pecuniary interests therein."}],"balance_after":104000,"source":{"system":"sec-edgar","filing":"0001193125-26-036387","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1865779/000119312526036387/ownership.xml","form_type":"4"}},{"id":922139,"issuer":{"id":6966,"kind":"organization","name":"RAPID MICRO BIOSYSTEMS, INC."},"owners":[{"id":67420,"kind":"organization","name":"Longitude Capital Partners II, LLC","position":1,"cik":"0001647491","reported_name":"Longitude Capital Partners II, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67421,"kind":"organization","name":"Longitude Venture Partners II, L.P.","position":2,"cik":"0001527510","reported_name":"Longitude Venture Partners II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67422,"kind":"organization","name":"Longitude Prime Partners, LLC","position":3,"cik":"0001865779","reported_name":"Longitude Prime Partners, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":847,"kind":"person","name":"ENRIGHT PATRICK G","position":4,"cik":"0001253886","reported_name":"ENRIGHT PATRICK G","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36915,"kind":"person","name":"Tammenoms Bakker Juliet","position":5,"cik":"0001431159","reported_name":"Tammenoms Bakker Juliet","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2026-02-03T20:50:11.000Z","date":"2026-01-23","kind":"sale","planned":false,"acquired":false,"shares":7739,"price":4.064,"value":31451.296,"ownership":{"direct":false,"nature":"Held by Longitude Venture Partners II, L.P."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Longitude Venture Partners II, L.P. (\"LVPII\") exercised warrants to purchase an aggregate of 629,032 shares of the Issuer's Class A common stock for $0.05 per share and paid the exercise price on a cashless basis, resulting in the Issuer withholding 7,739 shares of the Issuer's shares of Class A common stock subject to the warrant to pay the exercise price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities are held directly by LVPII. Longitude Capital Partners II, LLC, (\"LCPII\"), the general partner of LVPII, may be deemed to have voting and dispositive power with respect to the shares held by LVPII. Patrick G. Enright and Juliet Tammenoms Bakker are the managing members of LCPII and may be deemed to share voting and dispositive power over the shares held by LVPII. Each of LCPII, Mr. Enright and Ms. Tammenoms Bakker disclaim beneficial ownership of such securities and this report shall not be deemed an admission that any one of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interest therein."}],"balance_after":4029245,"source":{"system":"sec-edgar","filing":"0001193125-26-036387","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1865779/000119312526036387/ownership.xml","form_type":"4"}},{"id":922138,"issuer":{"id":6966,"kind":"organization","name":"RAPID MICRO BIOSYSTEMS, INC."},"owners":[{"id":67420,"kind":"organization","name":"Longitude Capital Partners II, LLC","position":1,"cik":"0001647491","reported_name":"Longitude Capital Partners II, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67421,"kind":"organization","name":"Longitude Venture Partners II, L.P.","position":2,"cik":"0001527510","reported_name":"Longitude Venture Partners II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67422,"kind":"organization","name":"Longitude Prime Partners, LLC","position":3,"cik":"0001865779","reported_name":"Longitude Prime Partners, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":847,"kind":"person","name":"ENRIGHT PATRICK G","position":4,"cik":"0001253886","reported_name":"ENRIGHT PATRICK G","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36915,"kind":"person","name":"Tammenoms Bakker Juliet","position":5,"cik":"0001431159","reported_name":"Tammenoms Bakker Juliet","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2026-02-03T20:50:11.000Z","date":"2026-01-23","kind":"other","planned":false,"acquired":true,"shares":629032,"price":0.05,"value":31451.6,"ownership":{"direct":false,"nature":"Held by Longitude Venture Partners II, L.P."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Longitude Venture Partners II, L.P. (\"LVPII\") exercised warrants to purchase an aggregate of 629,032 shares of the Issuer's Class A common stock for $0.05 per share and paid the exercise price on a cashless basis, resulting in the Issuer withholding 7,739 shares of the Issuer's shares of Class A common stock subject to the warrant to pay the exercise price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities are held directly by LVPII. Longitude Capital Partners II, LLC, (\"LCPII\"), the general partner of LVPII, may be deemed to have voting and dispositive power with respect to the shares held by LVPII. Patrick G. Enright and Juliet Tammenoms Bakker are the managing members of LCPII and may be deemed to share voting and dispositive power over the shares held by LVPII. Each of LCPII, Mr. Enright and Ms. Tammenoms Bakker disclaim beneficial ownership of such securities and this report shall not be deemed an admission that any one of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interest therein."}],"balance_after":4036984,"source":{"system":"sec-edgar","filing":"0001193125-26-036387","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1865779/000119312526036387/ownership.xml","form_type":"4"}},{"id":943113,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":847,"kind":"person","name":"ENRIGHT PATRICK G","position":1,"cik":"0001253886","reported_name":"ENRIGHT PATRICK G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2026-01-08T22:56:44.000Z","date":"2025-08-18","kind":"other","planned":false,"acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares transferred to former spouse without consideration as part of a comprehensive division of marital assets. Following the transfer, the reporting person no longer has beneficial ownership of the transferred shares."}],"balance_after":21379,"source":{"system":"sec-edgar","filing":"0001253886-26-000002","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000125388626000002/edgardoc.xml","form_type":"4"}},{"id":969101,"issuer":{"id":4358,"kind":"organization","name":"Vera Therapeutics, Inc.","symbol":"VERA"},"owners":[{"id":847,"kind":"person","name":"ENRIGHT PATRICK G","position":1,"cik":"0001253886","reported_name":"ENRIGHT PATRICK G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2025-12-16T01:07:34.000Z","date":"2025-12-11","kind":"purchase","planned":false,"acquired":true,"shares":5882,"price":42.5,"value":249985.0,"ownership":{"direct":true},"balance_after":5882,"source":{"system":"sec-edgar","filing":"0001193125-25-319649","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1253886/000119312525319649/ownership.xml","form_type":"4"}},{"id":1019085,"issuer":{"id":275,"kind":"organization","name":"Zenas BioPharma, Inc.","symbol":"ZBIO"},"owners":[{"id":847,"kind":"person","name":"ENRIGHT PATRICK G","position":1,"cik":"0001253886","reported_name":"ENRIGHT PATRICK G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-10-14T12:59:40.000Z","date":"2025-10-09","kind":"purchase","planned":false,"acquired":true,"shares":11990,"price":20.85,"value":249991.5,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On October 7, 2025, the Issuer entered into a Securities Purchase Agreement with certain investors, including the Reporting Person and Longitude Venture Partners IV, L.P. (\"LVPIV\")  pursuant to which the Reporting Person purchased 11,990 shares of common stock at a price per share of $20.85 and LVPIV purchased 105,265 shares of common stock as a price per share of $19.00 (the \"Offering\"). The Offering closed on October 9, 2025."}],"balance_after":11990,"source":{"system":"sec-edgar","filing":"0001193125-25-238326","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1253886/000119312525238326/ownership.xml","form_type":"4"}},{"id":1019084,"issuer":{"id":275,"kind":"organization","name":"Zenas BioPharma, Inc.","symbol":"ZBIO"},"owners":[{"id":847,"kind":"person","name":"ENRIGHT PATRICK G","position":1,"cik":"0001253886","reported_name":"ENRIGHT PATRICK G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-10-14T12:59:40.000Z","date":"2025-10-09","kind":"purchase","planned":false,"acquired":true,"shares":105265,"price":19,"value":2000035.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On October 7, 2025, the Issuer entered into a Securities Purchase Agreement with certain investors, including the Reporting Person and Longitude Venture Partners IV, L.P. (\"LVPIV\")  pursuant to which the Reporting Person purchased 11,990 shares of common stock at a price per share of $20.85 and LVPIV purchased 105,265 shares of common stock as a price per share of $19.00 (the \"Offering\"). The Offering closed on October 9, 2025."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held by LVPIV. Longitude Capital Partners IV, LLC (\"LCPIV\") is the general partner of LVPIV and may be deemed to have voting, investment and dispositive power with respect to these securities. Juliet Tammenoms Bakker and the Reporting Person, a member of the board of directors of the Issuer, are the managing members of LCPIV and may each be deemed to share voting, investment and dispositive power with respect to these securities. Each of LCPIV, Ms. Bakker and the Reporting Person disclaims beneficial ownership of such securities except to the extent of their respective pecuniary interests therein."}],"balance_after":1832669,"source":{"system":"sec-edgar","filing":"0001193125-25-238326","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1253886/000119312525238326/ownership.xml","form_type":"4"}},{"id":1069965,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":847,"kind":"person","name":"ENRIGHT PATRICK G","position":1,"cik":"0001253886","reported_name":"ENRIGHT PATRICK G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2025-08-11T21:46:00.000Z","date":"2025-08-08","kind":"tax_withholding","planned":false,"acquired":false,"shares":1805,"price":111.2491,"value":200804.6255,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units."}],"balance_after":26379,"source":{"system":"sec-edgar","filing":"0001765581-25-000092","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558125000092/edgardoc.xml","form_type":"4"}},{"id":1069964,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":847,"kind":"person","name":"ENRIGHT PATRICK G","position":1,"cik":"0001253886","reported_name":"ENRIGHT PATRICK G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2025-08-11T21:46:00.000Z","date":"2025-08-07","kind":"grant","planned":false,"acquired":true,"shares":3507,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These restricted stock units are granted pursuant to the Issuer's 2007 Amended and Restated Non-Employee Directors Stock Award Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. Subject to the Reporting Person's continuous service and certain additional conditions, these units will vest in full on July 24, 2026."}],"balance_after":28184,"source":{"system":"sec-edgar","filing":"0001765581-25-000092","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558125000092/edgardoc.xml","form_type":"4"}},{"id":1101588,"issuer":{"id":4358,"kind":"organization","name":"Vera Therapeutics, Inc.","symbol":"VERA"},"owners":[{"id":847,"kind":"person","name":"ENRIGHT PATRICK G","position":1,"cik":"0001253886","reported_name":"ENRIGHT PATRICK G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2025-06-26T00:07:16.000Z","date":"2025-06-24","kind":"purchase","planned":false,"acquired":true,"shares":27071,"price":22.3517,"value":605082.8707,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were acquired in multiple transactions at prices ranging from $21.67 to $22.50, inclusive. The Reporting Person undertakes to provide to the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the ranges set forth in this footnote 4 to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These shares are held by Longitude Venture Partners IV, L.P (\"LVPIV\"). Longitude Capital Partners IV, LLC (\"LCPIV\") is the general partner of LVPIV and may be deemed to have voting and dispositive power over the shares held by LVPIV. The Reporting Person and Ms. Tammenoms Bakker are managing members of LCPIV and may be deemed to share voting and dispositive power with respect to the shares held by LVPIV. Each of LCPIV, the Reporting Person and Ms. Tammenoms Bakker disclaims beneficial ownership of such shares and this report shall not be deemed an admission that any of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein."}],"balance_after":3596593,"source":{"system":"sec-edgar","filing":"0000950170-25-090110","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1253886/000095017025090110/ownership.xml","form_type":"4"}},{"id":1101587,"issuer":{"id":4358,"kind":"organization","name":"Vera Therapeutics, Inc.","symbol":"VERA"},"owners":[{"id":847,"kind":"person","name":"ENRIGHT PATRICK G","position":1,"cik":"0001253886","reported_name":"ENRIGHT PATRICK G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2025-06-26T00:07:16.000Z","date":"2025-06-24","kind":"purchase","planned":false,"acquired":true,"shares":13536,"price":22.3517,"value":302552.6112,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were acquired in multiple transactions at prices ranging from $21.67 to $22.50, inclusive. The Reporting Person undertakes to provide to the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the ranges set forth in this footnote 4 to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held by Longitude Prime Fund, L.P. (\"LPF\"). Longitude Prime Partners, LLC (\"LPP\") is the general partner of LPF and may be deemed to have voting and investment power over the securities held by LPF. The Reporting Person and Juliet Tammenoms Bakker are the managing members of LPP and may be deemed to share voting and dispositive power over the shares held by LPF. Each of LPP, the Reporting Person and Ms. Tammenoms Bakker disclaims beneficial ownership of such shares and this report shall not be deemed an admission that any of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein."}],"balance_after":1797619,"source":{"system":"sec-edgar","filing":"0000950170-25-090110","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1253886/000095017025090110/ownership.xml","form_type":"4"}},{"id":1101586,"issuer":{"id":4358,"kind":"organization","name":"Vera Therapeutics, Inc.","symbol":"VERA"},"owners":[{"id":847,"kind":"person","name":"ENRIGHT PATRICK G","position":1,"cik":"0001253886","reported_name":"ENRIGHT PATRICK G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2025-06-26T00:07:16.000Z","date":"2025-06-23","kind":"purchase","planned":false,"acquired":true,"shares":139595,"price":20.8683,"value":2913110.3385,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were acquired in multiple transactions at prices ranging from $20.43 to $21.05, inclusive. The Reporting Person undertakes to provide to the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the ranges set forth in this footnote 1 to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These shares are held by Longitude Venture Partners IV, L.P (\"LVPIV\"). Longitude Capital Partners IV, LLC (\"LCPIV\") is the general partner of LVPIV and may be deemed to have voting and dispositive power over the shares held by LVPIV. The Reporting Person and Ms. Tammenoms Bakker are managing members of LCPIV and may be deemed to share voting and dispositive power with respect to the shares held by LVPIV. Each of LCPIV, the Reporting Person and Ms. Tammenoms Bakker disclaims beneficial ownership of such shares and this report shall not be deemed an admission that any of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein."}],"balance_after":3569522,"source":{"system":"sec-edgar","filing":"0000950170-25-090110","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1253886/000095017025090110/ownership.xml","form_type":"4"}},{"id":1101585,"issuer":{"id":4358,"kind":"organization","name":"Vera Therapeutics, Inc.","symbol":"VERA"},"owners":[{"id":847,"kind":"person","name":"ENRIGHT PATRICK G","position":1,"cik":"0001253886","reported_name":"ENRIGHT PATRICK G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2025-06-26T00:07:16.000Z","date":"2025-06-23","kind":"purchase","planned":false,"acquired":true,"shares":69798,"price":20.8683,"value":1456565.6034,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were acquired in multiple transactions at prices ranging from $20.43 to $21.05, inclusive. The Reporting Person undertakes to provide to the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the ranges set forth in this footnote 1 to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held by Longitude Prime Fund, L.P. (\"LPF\"). Longitude Prime Partners, LLC (\"LPP\") is the general partner of LPF and may be deemed to have voting and investment power over the securities held by LPF. The Reporting Person and Juliet Tammenoms Bakker are the managing members of LPP and may be deemed to share voting and dispositive power over the shares held by LPF. Each of LPP, the Reporting Person and Ms. Tammenoms Bakker disclaims beneficial ownership of such shares and this report shall not be deemed an admission that any of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein."}],"balance_after":1784083,"source":{"system":"sec-edgar","filing":"0000950170-25-090110","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1253886/000095017025090110/ownership.xml","form_type":"4"}},{"id":1113041,"issuer":{"id":275,"kind":"organization","name":"Zenas BioPharma, Inc.","symbol":"ZBIO"},"owners":[{"id":847,"kind":"person","name":"ENRIGHT PATRICK G","position":1,"cik":"0001253886","reported_name":"ENRIGHT PATRICK G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-12T20:33:05.000Z","date":"2025-06-10","kind":"grant","planned":false,"acquired":true,"shares":18500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests as to 100% of the underlying shares of common stock on June 10, 2026, the first anniversary of the vesting commencement date, subject to continued service."}],"balance_after":18500,"derivative":{"exercise_price":11.94,"expiration_date":"2035-06-10","underlying":"Common Stock","underlying_shares":18500},"source":{"system":"sec-edgar","filing":"0001104659-25-058924","document":"tm2517684-4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1253886/000110465925058924/tm2517684-4_4seq1.xml","form_type":"4"}},{"id":1117965,"issuer":{"id":5569,"kind":"organization","name":"BioAge Labs, Inc."},"owners":[{"id":847,"kind":"person","name":"ENRIGHT PATRICK G","position":1,"cik":"0001253886","reported_name":"ENRIGHT PATRICK G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-09T20:44:06.000Z","date":"2025-06-05","kind":"grant","planned":false,"acquired":true,"shares":22000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The entire option award shall vest on the earlier of:  (i) the date of the next annual meeting of the Issuer's stockholders or (ii) the one year anniversary of the grant date, subject to the reporting person's continued service to the Issuer on the applicable vesting date."}],"balance_after":22000,"derivative":{"exercise_price":4.44,"expiration_date":"2035-06-04","underlying":"Common Stock","underlying_shares":22000},"source":{"system":"sec-edgar","filing":"0001415889-25-016286","document":"form4-06092025_080600.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1709941/000141588925016286/form4-06092025_080600.xml","form_type":"4"}},{"id":1145019,"issuer":{"id":4358,"kind":"organization","name":"Vera Therapeutics, Inc.","symbol":"VERA"},"owners":[{"id":847,"kind":"person","name":"ENRIGHT PATRICK G","position":1,"cik":"0001253886","reported_name":"ENRIGHT PATRICK G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-05-16T20:13:01.000Z","date":"2025-05-14","kind":"grant","planned":false,"acquired":true,"shares":14000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest in full on the earlier of the first anniversary of the grant date or the date of the Company's 2026 annual stockholder meeting, subject to the Reporting Person's continuous service through such vesting date. Notwithstanding the foregoing, the shares will vest in full upon a change in control, subject to the Reporting Person's continuous service through the date of such change in control."}],"balance_after":14000,"derivative":{"exercise_price":21.19,"expiration_date":"2035-05-13","underlying":"Class A Common Stock","underlying_shares":14000},"source":{"system":"sec-edgar","filing":"0001415889-25-013421","document":"form4-05162025_080556.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1253886/000141588925013421/form4-05162025_080556.xml","form_type":"4"}},{"id":1398482,"issuer":{"id":5569,"kind":"organization","name":"BioAge Labs, Inc."},"owners":[{"id":847,"kind":"person","name":"ENRIGHT PATRICK G","position":1,"cik":"0001253886","reported_name":"ENRIGHT PATRICK G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series D Preferred Stock","published_at":"2024-09-27T20:26:41.000Z","date":"2024-09-27","kind":"exercise","planned":false,"acquired":false,"shares":5848637,"ownership":{"direct":false,"nature":"Longitude Venture Partners IV, L.P."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Pursuant to the Issuer's Restated Certificate of Incorporation, upon closing of the Issuer's initial public offering of its Common Stock, each share of Series D Convertible Preferred Stock automatically converted into shares of Common Stock at a ratio of 1-for-0.224084614.  The securities have no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to the Issuer's Restated Certificate of Incorporation, upon closing of the Issuer's initial public offering of its Common Stock, each share of Series D Convertible Preferred Stock automatically converted into shares of Common Stock at a ratio of 1-for-0.224084614.  The securities have no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Pursuant to the Issuer's Restated Certificate of Incorporation, upon closing of the Issuer's initial public offering of its Common Stock, each share of Series D Convertible Preferred Stock automatically converted into shares of Common Stock at a ratio of 1-for-0.224084614.  The securities have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Pursuant to the Issuer's Restated Certificate of Incorporation, upon closing of the Issuer's initial public offering of its Common Stock, each share of Series D Convertible Preferred Stock automatically converted into shares of Common Stock at a ratio of 1-for-0.224084614.  The securities have no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are directly held by Longitude Venture Partners IV, L.P (\"LVP IV\").  Longitude Capital Partners IV, LLC (\"LCP IV\") is the general partner of LVP IV and may be deemed to exercise voting and investment discretion with respect to securities held by LVP IV.  The reporting person and Ms. Juliet Tammenoms Bakker serve as the managing members of LCP IV and may be deemed to share voting and investment discretion with respect to securities held directly by LVP IV.  Each of LCP IV, Mr. Enright, and Ms. Tammenoms Bakker disclaims beneficial ownership of such securities and this report shall not be deemed an admission that any of them is the beneficial owner of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose, except to the extent of their respective pecuniary interests therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1310589},"source":{"system":"sec-edgar","filing":"0001415889-24-024046","document":"form4-09272024_080937.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1709941/000141588924024046/form4-09272024_080937.xml","form_type":"4"}},{"id":1398481,"issuer":{"id":5569,"kind":"organization","name":"BioAge Labs, Inc."},"owners":[{"id":847,"kind":"person","name":"ENRIGHT PATRICK G","position":1,"cik":"0001253886","reported_name":"ENRIGHT PATRICK G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-09-27T20:26:41.000Z","date":"2024-09-25","kind":"grant","planned":false,"acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The entire option award shall vest on the earlier of:  (i) the date of the next annual meeting of the Issuer's stockholders or (ii) the one year anniversary of the grant date, subject to the reporting person's continued service to the Issuer on the applicable vesting date."}],"balance_after":15000,"derivative":{"exercise_price":18,"expiration_date":"2034-09-24","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001415889-24-024046","document":"form4-09272024_080937.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1709941/000141588924024046/form4-09272024_080937.xml","form_type":"4"}},{"id":1398480,"issuer":{"id":5569,"kind":"organization","name":"BioAge Labs, Inc."},"owners":[{"id":847,"kind":"person","name":"ENRIGHT PATRICK G","position":1,"cik":"0001253886","reported_name":"ENRIGHT PATRICK G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-09-27T20:26:41.000Z","date":"2024-09-27","kind":"purchase","planned":false,"acquired":true,"shares":400000,"price":18,"value":7200000.0,"ownership":{"direct":false,"nature":"Longitude Venture Partners IV, L.P."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are directly held by Longitude Venture Partners IV, L.P (\"LVP IV\").  Longitude Capital Partners IV, LLC (\"LCP IV\") is the general partner of LVP IV and may be deemed to exercise voting and investment discretion with respect to securities held by LVP IV.  The reporting person and Ms. Juliet Tammenoms Bakker serve as the managing members of LCP IV and may be deemed to share voting and investment discretion with respect to securities held directly by LVP IV.  Each of LCP IV, Mr. Enright, and Ms. Tammenoms Bakker disclaims beneficial ownership of such securities and this report shall not be deemed an admission that any of them is the beneficial owner of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose, except to the extent of their respective pecuniary interests therein."}],"balance_after":1710589,"source":{"system":"sec-edgar","filing":"0001415889-24-024046","document":"form4-09272024_080937.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1709941/000141588924024046/form4-09272024_080937.xml","form_type":"4"}},{"id":1398479,"issuer":{"id":5569,"kind":"organization","name":"BioAge Labs, Inc."},"owners":[{"id":847,"kind":"person","name":"ENRIGHT PATRICK G","position":1,"cik":"0001253886","reported_name":"ENRIGHT PATRICK G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-09-27T20:26:41.000Z","date":"2024-09-27","kind":"exercise","planned":false,"acquired":true,"shares":1310589,"ownership":{"direct":false,"nature":"Longitude Venture Partners IV, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to the Issuer's Restated Certificate of Incorporation, upon closing of the Issuer's initial public offering of its Common Stock, each share of Series D Convertible Preferred Stock automatically converted into shares of Common Stock at a ratio of 1-for-0.224084614.  The securities have no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are directly held by Longitude Venture Partners IV, L.P (\"LVP IV\").  Longitude Capital Partners IV, LLC (\"LCP IV\") is the general partner of LVP IV and may be deemed to exercise voting and investment discretion with respect to securities held by LVP IV.  The reporting person and Ms. Juliet Tammenoms Bakker serve as the managing members of LCP IV and may be deemed to share voting and investment discretion with respect to securities held directly by LVP IV.  Each of LCP IV, Mr. Enright, and Ms. Tammenoms Bakker disclaims beneficial ownership of such securities and this report shall not be deemed an admission that any of them is the beneficial owner of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose, except to the extent of their respective pecuniary interests therein."}],"balance_after":1310589,"source":{"system":"sec-edgar","filing":"0001415889-24-024046","document":"form4-09272024_080937.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1709941/000141588924024046/form4-09272024_080937.xml","form_type":"4"}},{"id":1406495,"issuer":{"id":275,"kind":"organization","name":"Zenas BioPharma, Inc.","symbol":"ZBIO"},"owners":[{"id":847,"kind":"person","name":"ENRIGHT PATRICK G","position":1,"cik":"0001253886","reported_name":"ENRIGHT PATRICK G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-09-17T00:57:32.000Z","date":"2024-09-12","kind":"grant","planned":false,"acquired":true,"shares":37000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The option vests in equal annual installments over three years beginning on September 12, 2025, the first anniversary of the vesting commencement date, subject to continued service."}],"balance_after":37000,"derivative":{"exercise_price":17,"expiration_date":"2034-09-11","underlying":"Common Stock","underlying_shares":37000},"source":{"system":"sec-edgar","filing":"0001104659-24-100333","document":"tm2424157-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1253886/000110465924100333/tm2424157-3_4seq1.xml","form_type":"4"}},{"id":1406494,"issuer":{"id":275,"kind":"organization","name":"Zenas BioPharma, Inc.","symbol":"ZBIO"},"owners":[{"id":847,"kind":"person","name":"ENRIGHT PATRICK G","position":1,"cik":"0001253886","reported_name":"ENRIGHT PATRICK G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series C Convertible Preferred Stock","published_at":"2024-09-17T00:57:32.000Z","date":"2024-09-16","kind":"exercise","planned":false,"acquired":false,"shares":2904764,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"On September 16, 2024, the shares of Series C Convertible Preferred Stock automatically converted into shares of Common Stock on a 8.6831-for-1 basis without payment of further consideration upon the closing of the Issuer's initial public offering. The shares have no expiration date."},{"field":"shares","element":"transactionShares","label":"F5","text":"Shares held by LPF."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On September 16, 2024, the shares of Series B Convertible Preferred Stock automatically converted into shares of Common Stock on a 8.6831-for-1 basis without payment of further consideration upon the closing of the Issuer's initial public offering. The shares have no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On September 16, 2024, the shares of Series C Convertible Preferred Stock automatically converted into shares of Common Stock on a 8.6831-for-1 basis without payment of further consideration upon the closing of the Issuer's initial public offering. The shares have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"On September 16, 2024, the shares of Series C Convertible Preferred Stock automatically converted into shares of Common Stock on a 8.6831-for-1 basis without payment of further consideration upon the closing of the Issuer's initial public offering. The shares have no expiration date."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F5","text":"Shares held by LPF."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Longitude Capital Partners IV, LLC (\"LCPIV\") is the general partner of LVPIV and may be deemed to have voting, investment and dispositive power with respect to these securities. Longitude Prime Partners, LLC (\"LPP\") is the general partner of Longitude Prime Fund, L.P. (\"LPF\") and may be deemed to have voting, investment and dispositive power with respect to the securities held by LPF. Juliet Tammenoms Bakker and Patrick G. Enright, a member of the board of directors of the Issuer, are the managing members of LCPIV and LPP and may each be deemed to share voting, investment and dispositive power with respect to these securities. Each of LCPIV, LPP, Ms. Bakker and Mr. Enright disclaims beneficial ownership of such securities except to the extent of their respective pecuniary interests therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":334530},"source":{"system":"sec-edgar","filing":"0001104659-24-100333","document":"tm2424157-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1253886/000110465924100333/tm2424157-3_4seq1.xml","form_type":"4"}},{"id":1406493,"issuer":{"id":275,"kind":"organization","name":"Zenas BioPharma, Inc.","symbol":"ZBIO"},"owners":[{"id":847,"kind":"person","name":"ENRIGHT PATRICK G","position":1,"cik":"0001253886","reported_name":"ENRIGHT PATRICK G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series C Convertible Preferred Stock","published_at":"2024-09-17T00:57:32.000Z","date":"2024-09-16","kind":"exercise","planned":false,"acquired":false,"shares":8714293,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"On September 16, 2024, the shares of Series C Convertible Preferred Stock automatically converted into shares of Common Stock on a 8.6831-for-1 basis without payment of further consideration upon the closing of the Issuer's initial public offering. The shares have no expiration date."},{"field":"shares","element":"transactionShares","label":"F2","text":"Shares held by Longitude Venture Partners IV, L.P. (\"LVPIV\")."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On September 16, 2024, the shares of Series B Convertible Preferred Stock automatically converted into shares of Common Stock on a 8.6831-for-1 basis without payment of further consideration upon the closing of the Issuer's initial public offering. The shares have no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On September 16, 2024, the shares of Series C Convertible Preferred Stock automatically converted into shares of Common Stock on a 8.6831-for-1 basis without payment of further consideration upon the closing of the Issuer's initial public offering. The shares have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"On September 16, 2024, the shares of Series C Convertible Preferred Stock automatically converted into shares of Common Stock on a 8.6831-for-1 basis without payment of further consideration upon the closing of the Issuer's initial public offering. The shares have no expiration date."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F2","text":"Shares held by Longitude Venture Partners IV, L.P. (\"LVPIV\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Longitude Capital Partners IV, LLC (\"LCPIV\") is the general partner of LVPIV and may be deemed to have voting, investment and dispositive power with respect to these securities. Longitude Prime Partners, LLC (\"LPP\") is the general partner of Longitude Prime Fund, L.P. (\"LPF\") and may be deemed to have voting, investment and dispositive power with respect to the securities held by LPF. Juliet Tammenoms Bakker and Patrick G. Enright, a member of the board of directors of the Issuer, are the managing members of LCPIV and LPP and may each be deemed to share voting, investment and dispositive power with respect to these securities. Each of LCPIV, LPP, Ms. Bakker and Mr. Enright disclaims beneficial ownership of such securities except to the extent of their respective pecuniary interests therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1003592},"source":{"system":"sec-edgar","filing":"0001104659-24-100333","document":"tm2424157-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1253886/000110465924100333/tm2424157-3_4seq1.xml","form_type":"4"}},{"id":1406492,"issuer":{"id":275,"kind":"organization","name":"Zenas BioPharma, Inc.","symbol":"ZBIO"},"owners":[{"id":847,"kind":"person","name":"ENRIGHT PATRICK G","position":1,"cik":"0001253886","reported_name":"ENRIGHT PATRICK G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series B Convertible Preferred Stock","published_at":"2024-09-17T00:57:32.000Z","date":"2024-09-16","kind":"exercise","planned":false,"acquired":false,"shares":6284933,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"On September 16, 2024, the shares of Series B Convertible Preferred Stock automatically converted into shares of Common Stock on a 8.6831-for-1 basis without payment of further consideration upon the closing of the Issuer's initial public offering. The shares have no expiration date."},{"field":"shares","element":"transactionShares","label":"F2","text":"Shares held by Longitude Venture Partners IV, L.P. (\"LVPIV\")."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On September 16, 2024, the shares of Series B Convertible Preferred Stock automatically converted into shares of Common Stock on a 8.6831-for-1 basis without payment of further consideration upon the closing of the Issuer's initial public offering. The shares have no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On September 16, 2024, the shares of Series B Convertible Preferred Stock automatically converted into shares of Common Stock on a 8.6831-for-1 basis without payment of further consideration upon the closing of the Issuer's initial public offering. The shares have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On September 16, 2024, the shares of Series B Convertible Preferred Stock automatically converted into shares of Common Stock on a 8.6831-for-1 basis without payment of further consideration upon the closing of the Issuer's initial public offering. The shares have no expiration date."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F2","text":"Shares held by Longitude Venture Partners IV, L.P. (\"LVPIV\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Longitude Capital Partners IV, LLC (\"LCPIV\") is the general partner of LVPIV and may be deemed to have voting, investment and dispositive power with respect to these securities. Longitude Prime Partners, LLC (\"LPP\") is the general partner of Longitude Prime Fund, L.P. (\"LPF\") and may be deemed to have voting, investment and dispositive power with respect to the securities held by LPF. Juliet Tammenoms Bakker and Patrick G. Enright, a member of the board of directors of the Issuer, are the managing members of LCPIV and LPP and may each be deemed to share voting, investment and dispositive power with respect to these securities. Each of LCPIV, LPP, Ms. Bakker and Mr. Enright disclaims beneficial ownership of such securities except to the extent of their respective pecuniary interests therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":723812},"source":{"system":"sec-edgar","filing":"0001104659-24-100333","document":"tm2424157-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1253886/000110465924100333/tm2424157-3_4seq1.xml","form_type":"4"}},{"id":1406491,"issuer":{"id":275,"kind":"organization","name":"Zenas BioPharma, Inc.","symbol":"ZBIO"},"owners":[{"id":847,"kind":"person","name":"ENRIGHT PATRICK G","position":1,"cik":"0001253886","reported_name":"ENRIGHT PATRICK G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-09-17T00:57:32.000Z","date":"2024-09-16","kind":"purchase","planned":false,"acquired":true,"shares":440000,"price":17,"value":7480000.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"Shares held by LPF."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Longitude Capital Partners IV, LLC (\"LCPIV\") is the general partner of LVPIV and may be deemed to have voting, investment and dispositive power with respect to these securities. Longitude Prime Partners, LLC (\"LPP\") is the general partner of Longitude Prime Fund, L.P. (\"LPF\") and may be deemed to have voting, investment and dispositive power with respect to the securities held by LPF. Juliet Tammenoms Bakker and Patrick G. Enright, a member of the board of directors of the Issuer, are the managing members of LCPIV and LPP and may each be deemed to share voting, investment and dispositive power with respect to these securities. Each of LCPIV, LPP, Ms. Bakker and Mr. Enright disclaims beneficial ownership of such securities except to the extent of their respective pecuniary interests therein."}],"balance_after":774530,"source":{"system":"sec-edgar","filing":"0001104659-24-100333","document":"tm2424157-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1253886/000110465924100333/tm2424157-3_4seq1.xml","form_type":"4"}},{"id":1406490,"issuer":{"id":275,"kind":"organization","name":"Zenas BioPharma, Inc.","symbol":"ZBIO"},"owners":[{"id":847,"kind":"person","name":"ENRIGHT PATRICK G","position":1,"cik":"0001253886","reported_name":"ENRIGHT PATRICK G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-09-17T00:57:32.000Z","date":"2024-09-16","kind":"exercise","planned":false,"acquired":true,"shares":334530,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"On September 16, 2024, the shares of Series C Convertible Preferred Stock automatically converted into shares of Common Stock on a 8.6831-for-1 basis without payment of further consideration upon the closing of the Issuer's initial public offering. The shares have no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"On September 16, 2024, the shares of Series C Convertible Preferred Stock automatically converted into shares of Common Stock on a 8.6831-for-1 basis without payment of further consideration upon the closing of the Issuer's initial public offering. The shares have no expiration date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"Shares held by LPF."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Longitude Capital Partners IV, LLC (\"LCPIV\") is the general partner of LVPIV and may be deemed to have voting, investment and dispositive power with respect to these securities. Longitude Prime Partners, LLC (\"LPP\") is the general partner of Longitude Prime Fund, L.P. (\"LPF\") and may be deemed to have voting, investment and dispositive power with respect to the securities held by LPF. Juliet Tammenoms Bakker and Patrick G. Enright, a member of the board of directors of the Issuer, are the managing members of LCPIV and LPP and may each be deemed to share voting, investment and dispositive power with respect to these securities. Each of LCPIV, LPP, Ms. Bakker and Mr. Enright disclaims beneficial ownership of such securities except to the extent of their respective pecuniary interests therein."}],"balance_after":334530,"source":{"system":"sec-edgar","filing":"0001104659-24-100333","document":"tm2424157-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1253886/000110465924100333/tm2424157-3_4seq1.xml","form_type":"4"}},{"id":1406489,"issuer":{"id":275,"kind":"organization","name":"Zenas BioPharma, Inc.","symbol":"ZBIO"},"owners":[{"id":847,"kind":"person","name":"ENRIGHT PATRICK G","position":1,"cik":"0001253886","reported_name":"ENRIGHT PATRICK G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-09-17T00:57:32.000Z","date":"2024-09-16","kind":"exercise","planned":false,"acquired":true,"shares":1003592,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"On September 16, 2024, the shares of Series C Convertible Preferred Stock automatically converted into shares of Common Stock on a 8.6831-for-1 basis without payment of further consideration upon the closing of the Issuer's initial public offering. The shares have no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"On September 16, 2024, the shares of Series C Convertible Preferred Stock automatically converted into shares of Common Stock on a 8.6831-for-1 basis without payment of further consideration upon the closing of the Issuer's initial public offering. The shares have no expiration date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Shares held by Longitude Venture Partners IV, L.P. (\"LVPIV\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Longitude Capital Partners IV, LLC (\"LCPIV\") is the general partner of LVPIV and may be deemed to have voting, investment and dispositive power with respect to these securities. Longitude Prime Partners, LLC (\"LPP\") is the general partner of Longitude Prime Fund, L.P. (\"LPF\") and may be deemed to have voting, investment and dispositive power with respect to the securities held by LPF. Juliet Tammenoms Bakker and Patrick G. Enright, a member of the board of directors of the Issuer, are the managing members of LCPIV and LPP and may each be deemed to share voting, investment and dispositive power with respect to these securities. Each of LCPIV, LPP, Ms. Bakker and Mr. Enright disclaims beneficial ownership of such securities except to the extent of their respective pecuniary interests therein."}],"balance_after":1727404,"source":{"system":"sec-edgar","filing":"0001104659-24-100333","document":"tm2424157-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1253886/000110465924100333/tm2424157-3_4seq1.xml","form_type":"4"}},{"id":1406488,"issuer":{"id":275,"kind":"organization","name":"Zenas BioPharma, Inc.","symbol":"ZBIO"},"owners":[{"id":847,"kind":"person","name":"ENRIGHT PATRICK G","position":1,"cik":"0001253886","reported_name":"ENRIGHT PATRICK G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-09-17T00:57:32.000Z","date":"2024-09-16","kind":"exercise","planned":false,"acquired":true,"shares":723812,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On September 16, 2024, the shares of Series B Convertible Preferred Stock automatically converted into shares of Common Stock on a 8.6831-for-1 basis without payment of further consideration upon the closing of the Issuer's initial public offering. The shares have no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On September 16, 2024, the shares of Series B Convertible Preferred Stock automatically converted into shares of Common Stock on a 8.6831-for-1 basis without payment of further consideration upon the closing of the Issuer's initial public offering. The shares have no expiration date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Shares held by Longitude Venture Partners IV, L.P. (\"LVPIV\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Longitude Capital Partners IV, LLC (\"LCPIV\") is the general partner of LVPIV and may be deemed to have voting, investment and dispositive power with respect to these securities. Longitude Prime Partners, LLC (\"LPP\") is the general partner of Longitude Prime Fund, L.P. (\"LPF\") and may be deemed to have voting, investment and dispositive power with respect to the securities held by LPF. Juliet Tammenoms Bakker and Patrick G. Enright, a member of the board of directors of the Issuer, are the managing members of LCPIV and LPP and may each be deemed to share voting, investment and dispositive power with respect to these securities. Each of LCPIV, LPP, Ms. Bakker and Mr. Enright disclaims beneficial ownership of such securities except to the extent of their respective pecuniary interests therein."}],"balance_after":723812,"source":{"system":"sec-edgar","filing":"0001104659-24-100333","document":"tm2424157-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1253886/000110465924100333/tm2424157-3_4seq1.xml","form_type":"4"}},{"id":1439509,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":847,"kind":"person","name":"ENRIGHT PATRICK G","position":1,"cik":"0001253886","reported_name":"ENRIGHT PATRICK G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2024-08-06T22:45:01.000Z","date":"2024-08-02","kind":"grant","planned":false,"acquired":true,"shares":3731,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These restricted stock units are granted pursuant to the Issuer's 2007 Amended and Restated Non-Employee Directors Stock Award Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. Subject to the Reporting Person's continuous service and certain additional conditions, these units will vest in full on July 25, 2025."}],"balance_after":24677,"source":{"system":"sec-edgar","filing":"0001765581-24-000080","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558124000080/edgardoc.xml","form_type":"4"}},{"id":1510871,"issuer":{"id":4358,"kind":"organization","name":"Vera Therapeutics, Inc.","symbol":"VERA"},"owners":[{"id":847,"kind":"person","name":"ENRIGHT PATRICK G","position":1,"cik":"0001253886","reported_name":"ENRIGHT PATRICK G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-05-17T20:10:26.000Z","date":"2024-05-15","kind":"grant","planned":false,"acquired":true,"shares":14000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest in full on the earlier of the first anniversary of the grant date or the date of the Company's 2025 annual stockholder meeting, subject to the Reporting Person's continuous service through such vesting date. Notwithstanding the foregoing, the shares will vest in full upon a change in control, subject to the Reporting Person's continuous service through the date of such change in control."}],"balance_after":14000,"derivative":{"exercise_price":42.69,"expiration_date":"2034-05-14","underlying":"Class A Common Stock","underlying_shares":14000},"source":{"system":"sec-edgar","filing":"0001415889-24-013472","document":"form4-05172024_080506.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1253886/000141588924013472/form4-05172024_080506.xml","form_type":"4"}},{"id":1745655,"issuer":{"id":5687,"kind":"organization","name":"Lexeo Therapeutics, Inc.","symbol":"LXEO"},"owners":[{"id":108417,"kind":"organization","name":"Longitude Capital Partners IV, LLC","position":1,"cik":"0001829169","reported_name":"Longitude Capital Partners IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":108418,"kind":"organization","name":"Longitude Venture Partners IV, L.P.","position":2,"cik":"0001787456","reported_name":"Longitude Venture Partners IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36915,"kind":"person","name":"Tammenoms Bakker Juliet","position":3,"cik":"0001431159","reported_name":"Tammenoms Bakker Juliet","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":847,"kind":"person","name":"ENRIGHT PATRICK G","position":4,"cik":"0001253886","reported_name":"ENRIGHT PATRICK G","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B convertible preferred stock","published_at":"2023-11-10T01:32:53.000Z","date":"2023-11-07","kind":"exercise","planned":false,"acquired":false,"shares":2906148,"ownership":{"direct":false,"nature":"By Longitude Venture Partners IV, L.P."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Upon the closing of the Issuer's initial public offering, each share of Series B convertible preferred stock automatically converted into shares of the Issuer's common stock on a one-for-9.106601 basis, which reflects an anti-dilution adjustment to the conversion ratio pursuant to a provision of the Series B convertible preferred stock based on the pricing of the initial public offering (as described in the Reporting Person's Form 3). The shares had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Upon the closing of the Issuer's initial public offering, each share of Series B convertible preferred stock automatically converted into shares of the Issuer's common stock on a one-for-9.106601 basis, which reflects an anti-dilution adjustment to the conversion ratio pursuant to a provision of the Series B convertible preferred stock based on the pricing of the initial public offering (as described in the Reporting Person's Form 3). The shares had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Upon the closing of the Issuer's initial public offering, each share of Series B convertible preferred stock automatically converted into shares of the Issuer's common stock on a one-for-9.106601 basis, which reflects an anti-dilution adjustment to the conversion ratio pursuant to a provision of the Series B convertible preferred stock based on the pricing of the initial public offering (as described in the Reporting Person's Form 3). The shares had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Upon the closing of the Issuer's initial public offering, each share of Series B convertible preferred stock automatically converted into shares of the Issuer's common stock on a one-for-9.106601 basis, which reflects an anti-dilution adjustment to the conversion ratio pursuant to a provision of the Series B convertible preferred stock based on the pricing of the initial public offering (as described in the Reporting Person's Form 3). The shares had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held by Longitude Venture Partners IV, L.P (\"LVP IV\"). Longitude Capital Partners IV, LLC (\"LCP IV\") is the general partner of LVP IV and may be deemed to have voting and dispositive power over the shares held by LVP IV. Mr. Enright and Ms. Tammenoms Bakker are managing members of LCP IV and may be deemed to share voting and dispositive power with respect to the shares held by LVP IV. Each of LCP IV, Mr. Enright and Ms. Tammenoms Bakker disclaims beneficial ownership of such shares and this report shall not be deemed an admission that any of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":319126},"source":{"system":"sec-edgar","filing":"0001209191-23-054904","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1431159/000120919123054904/doc4.xml","form_type":"4"}},{"id":1745654,"issuer":{"id":5687,"kind":"organization","name":"Lexeo Therapeutics, Inc.","symbol":"LXEO"},"owners":[{"id":108417,"kind":"organization","name":"Longitude Capital Partners IV, LLC","position":1,"cik":"0001829169","reported_name":"Longitude Capital Partners IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":108418,"kind":"organization","name":"Longitude Venture Partners IV, L.P.","position":2,"cik":"0001787456","reported_name":"Longitude Venture Partners IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36915,"kind":"person","name":"Tammenoms Bakker Juliet","position":3,"cik":"0001431159","reported_name":"Tammenoms Bakker Juliet","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":847,"kind":"person","name":"ENRIGHT PATRICK G","position":4,"cik":"0001253886","reported_name":"ENRIGHT PATRICK G","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A convertible preferred stock","published_at":"2023-11-10T01:32:53.000Z","date":"2023-11-07","kind":"exercise","planned":false,"acquired":false,"shares":18999999,"ownership":{"direct":false,"nature":"By Longitude Venture Partners IV, L.P."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Upon the closing of the Issuer's initial public offering, each share of Series A convertible preferred stock automatically converted into shares of the Issuer's common stock on a one-for-10.594230 basis. The shares had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Upon the closing of the Issuer's initial public offering, each share of Series A convertible preferred stock automatically converted into shares of the Issuer's common stock on a one-for-10.594230 basis. The shares had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Upon the closing of the Issuer's initial public offering, each share of Series A convertible preferred stock automatically converted into shares of the Issuer's common stock on a one-for-10.594230 basis. The shares had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Upon the closing of the Issuer's initial public offering, each share of Series A convertible preferred stock automatically converted into shares of the Issuer's common stock on a one-for-10.594230 basis. The shares had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held by Longitude Venture Partners IV, L.P (\"LVP IV\"). Longitude Capital Partners IV, LLC (\"LCP IV\") is the general partner of LVP IV and may be deemed to have voting and dispositive power over the shares held by LVP IV. Mr. Enright and Ms. Tammenoms Bakker are managing members of LCP IV and may be deemed to share voting and dispositive power with respect to the shares held by LVP IV. Each of LCP IV, Mr. Enright and Ms. Tammenoms Bakker disclaims beneficial ownership of such shares and this report shall not be deemed an admission that any of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1793429},"source":{"system":"sec-edgar","filing":"0001209191-23-054904","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1431159/000120919123054904/doc4.xml","form_type":"4"}},{"id":1745653,"issuer":{"id":5687,"kind":"organization","name":"Lexeo Therapeutics, Inc.","symbol":"LXEO"},"owners":[{"id":108417,"kind":"organization","name":"Longitude Capital Partners IV, LLC","position":1,"cik":"0001829169","reported_name":"Longitude Capital Partners IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":108418,"kind":"organization","name":"Longitude Venture Partners IV, L.P.","position":2,"cik":"0001787456","reported_name":"Longitude Venture Partners IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36915,"kind":"person","name":"Tammenoms Bakker Juliet","position":3,"cik":"0001431159","reported_name":"Tammenoms Bakker Juliet","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":847,"kind":"person","name":"ENRIGHT PATRICK G","position":4,"cik":"0001253886","reported_name":"ENRIGHT PATRICK G","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-11-10T01:32:53.000Z","date":"2023-11-07","kind":"purchase","planned":false,"acquired":true,"shares":454545,"price":11,"value":4999995.0,"ownership":{"direct":false,"nature":"By Longitude Venture Partners IV, L.P."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held by Longitude Venture Partners IV, L.P (\"LVP IV\"). Longitude Capital Partners IV, LLC (\"LCP IV\") is the general partner of LVP IV and may be deemed to have voting and dispositive power over the shares held by LVP IV. Mr. Enright and Ms. Tammenoms Bakker are managing members of LCP IV and may be deemed to share voting and dispositive power with respect to the shares held by LVP IV. Each of LCP IV, Mr. Enright and Ms. Tammenoms Bakker disclaims beneficial ownership of such shares and this report shall not be deemed an admission that any of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein."}],"balance_after":2567100,"source":{"system":"sec-edgar","filing":"0001209191-23-054904","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1431159/000120919123054904/doc4.xml","form_type":"4"}},{"id":1745652,"issuer":{"id":5687,"kind":"organization","name":"Lexeo Therapeutics, Inc.","symbol":"LXEO"},"owners":[{"id":108417,"kind":"organization","name":"Longitude Capital Partners IV, LLC","position":1,"cik":"0001829169","reported_name":"Longitude Capital Partners IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":108418,"kind":"organization","name":"Longitude Venture Partners IV, L.P.","position":2,"cik":"0001787456","reported_name":"Longitude Venture Partners IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36915,"kind":"person","name":"Tammenoms Bakker Juliet","position":3,"cik":"0001431159","reported_name":"Tammenoms Bakker Juliet","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":847,"kind":"person","name":"ENRIGHT PATRICK G","position":4,"cik":"0001253886","reported_name":"ENRIGHT PATRICK G","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-11-10T01:32:53.000Z","date":"2023-11-07","kind":"exercise","planned":false,"acquired":true,"shares":319126,"ownership":{"direct":false,"nature":"By Longitude Venture Partners IV, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Upon the closing of the Issuer's initial public offering, each share of Series B convertible preferred stock automatically converted into shares of the Issuer's common stock on a one-for-9.106601 basis, which reflects an anti-dilution adjustment to the conversion ratio pursuant to a provision of the Series B convertible preferred stock based on the pricing of the initial public offering (as described in the Reporting Person's Form 3). The shares had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held by Longitude Venture Partners IV, L.P (\"LVP IV\"). Longitude Capital Partners IV, LLC (\"LCP IV\") is the general partner of LVP IV and may be deemed to have voting and dispositive power over the shares held by LVP IV. Mr. Enright and Ms. Tammenoms Bakker are managing members of LCP IV and may be deemed to share voting and dispositive power with respect to the shares held by LVP IV. Each of LCP IV, Mr. Enright and Ms. Tammenoms Bakker disclaims beneficial ownership of such shares and this report shall not be deemed an admission that any of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein."}],"balance_after":2112555,"source":{"system":"sec-edgar","filing":"0001209191-23-054904","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1431159/000120919123054904/doc4.xml","form_type":"4"}},{"id":1745651,"issuer":{"id":5687,"kind":"organization","name":"Lexeo Therapeutics, Inc.","symbol":"LXEO"},"owners":[{"id":108417,"kind":"organization","name":"Longitude Capital Partners IV, LLC","position":1,"cik":"0001829169","reported_name":"Longitude Capital Partners IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":108418,"kind":"organization","name":"Longitude Venture Partners IV, L.P.","position":2,"cik":"0001787456","reported_name":"Longitude Venture Partners IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36915,"kind":"person","name":"Tammenoms Bakker Juliet","position":3,"cik":"0001431159","reported_name":"Tammenoms Bakker Juliet","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":847,"kind":"person","name":"ENRIGHT PATRICK G","position":4,"cik":"0001253886","reported_name":"ENRIGHT PATRICK G","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-11-10T01:32:53.000Z","date":"2023-11-07","kind":"exercise","planned":false,"acquired":true,"shares":1793429,"ownership":{"direct":false,"nature":"By Longitude Venture Partners IV, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Upon the closing of the Issuer's initial public offering, each share of Series A convertible preferred stock automatically converted into shares of the Issuer's common stock on a one-for-10.594230 basis. The shares had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held by Longitude Venture Partners IV, L.P (\"LVP IV\"). Longitude Capital Partners IV, LLC (\"LCP IV\") is the general partner of LVP IV and may be deemed to have voting and dispositive power over the shares held by LVP IV. Mr. Enright and Ms. Tammenoms Bakker are managing members of LCP IV and may be deemed to share voting and dispositive power with respect to the shares held by LVP IV. Each of LCP IV, Mr. Enright and Ms. Tammenoms Bakker disclaims beneficial ownership of such shares and this report shall not be deemed an admission that any of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein."}],"balance_after":1793429,"source":{"system":"sec-edgar","filing":"0001209191-23-054904","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1431159/000120919123054904/doc4.xml","form_type":"4"}},{"id":1807118,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":847,"kind":"person","name":"ENRIGHT PATRICK G","position":1,"cik":"0001253886","reported_name":"ENRIGHT PATRICK G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2023-08-15T21:45:56.000Z","date":"2023-08-14","kind":"sale","planned":false,"acquired":false,"shares":1241,"price":138.1585,"value":171454.6985,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $137.78 to $138.16. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected."}],"balance_after":20946,"source":{"system":"sec-edgar","filing":"0001765581-23-000078","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558123000078/edgardoc.xml","form_type":"4"}},{"id":1807117,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":847,"kind":"person","name":"ENRIGHT PATRICK G","position":1,"cik":"0001253886","reported_name":"ENRIGHT PATRICK G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2023-08-15T21:45:56.000Z","date":"2023-08-11","kind":"grant","planned":false,"acquired":true,"shares":3075,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Directors Stock Award Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. Subject to the Reporting Person's continuous service and certain additional conditions, these units will vest in full on August 3, 2024."}],"balance_after":22187,"source":{"system":"sec-edgar","filing":"0001765581-23-000078","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558123000078/edgardoc.xml","form_type":"4"}},{"id":1894830,"issuer":{"id":4358,"kind":"organization","name":"Vera Therapeutics, Inc.","symbol":"VERA"},"owners":[{"id":847,"kind":"person","name":"ENRIGHT PATRICK G","position":1,"cik":"0001253886","reported_name":"ENRIGHT PATRICK G","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-05-12T20:12:14.000Z","date":"2023-05-10","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest in full on the earlier of the first anniversary of the grant date or the date of the Company's 2024 annual stockholder meeting, subject to the Reporting Person's continuous service through such vesting date. Notwithstanding the foregoing, the shares will vest in full upon a change in control, subject to the Reporting Person's continuous service through the date of such change in control."}],"balance_after":20000,"derivative":{"exercise_price":7.7,"expiration_date":"2033-05-09","underlying":"Class A Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001209191-23-029014","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1253886/000120919123029014/doc4.xml","form_type":"4"}},{"id":2026301,"issuer":{"id":4358,"kind":"organization","name":"Vera Therapeutics, Inc.","symbol":"VERA"},"owners":[{"id":847,"kind":"person","name":"ENRIGHT PATRICK G","position":1,"cik":"0001253886","reported_name":"ENRIGHT PATRICK G","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2023-02-09T00:32:52.000Z","date":"2023-02-06","kind":"purchase","acquired":true,"shares":1714285,"price":7,"value":11999995.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These shares are held by Longitude Prime Fund, L.P. (\"LPF\"). Longitude Prime Partners, LLC (\"LPP\") is the general partner of LPF and may be deemed to have voting and investment power over the securities held by LPF. Patrick G. Enright and Juliet Tammenoms Bakker are the managing members of LPP and may be deemed to share voting and dispositive power over the shares held by LPF. Each of LPP, Mr. Enright and Ms. Tammenoms Bakker disclaims beneficial ownership of such shares and this report shall not be deemed an admission that any of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein."}],"balance_after":1714285,"source":{"system":"sec-edgar","filing":"0000899243-23-004345","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1253886/000089924323004345/doc4.xml","form_type":"4"}},{"id":2104099,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":847,"kind":"person","name":"ENRIGHT PATRICK G","position":1,"cik":"0001253886","reported_name":"ENRIGHT PATRICK G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2022-11-26T02:33:16.000Z","date":"2022-11-22","kind":"sale","acquired":false,"shares":2000,"price":152.8757,"value":305751.4,"ownership":{"direct":false,"nature":"by Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $152.84 to $152.91. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"These shares were held by a trust (the \"Trust\"). Reporting person is the Trustee of the Trust and may be deemed to share voting, investment and dispositive power over the shares held by the Trust. Reporting person disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein and this report shall not be deemed an admission of beneficial ownership for purposes of Section 16 or for any other purpose."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001765581-22-000126","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558122000126/edgardoc.xml","form_type":"4"}},{"id":2104098,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":847,"kind":"person","name":"ENRIGHT PATRICK G","position":1,"cik":"0001253886","reported_name":"ENRIGHT PATRICK G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2022-11-26T02:33:16.000Z","date":"2022-11-22","kind":"sale","acquired":false,"shares":2069,"price":149.9028,"value":310148.8932,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $149.76 to $150.06. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected."}],"balance_after":19112,"source":{"system":"sec-edgar","filing":"0001765581-22-000126","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558122000126/edgardoc.xml","form_type":"4"}},{"id":2104097,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":847,"kind":"person","name":"ENRIGHT PATRICK G","position":1,"cik":"0001253886","reported_name":"ENRIGHT PATRICK G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2022-11-26T02:33:16.000Z","date":"2022-11-22","kind":"sale","acquired":false,"shares":2905,"price":149.1786,"value":433363.833,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $148.51 to $149.34. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected."}],"balance_after":21181,"source":{"system":"sec-edgar","filing":"0001765581-22-000126","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558122000126/edgardoc.xml","form_type":"4"}},{"id":2190627,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":847,"kind":"person","name":"ENRIGHT PATRICK G","position":1,"cik":"0001253886","reported_name":"ENRIGHT PATRICK G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2022-08-09T22:12:33.000Z","date":"2022-08-08","kind":"sale","acquired":false,"shares":1089,"price":152.3264,"value":165883.4496,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units."}],"balance_after":24086,"source":{"system":"sec-edgar","filing":"0001765581-22-000084","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558122000084/edgardoc.xml","form_type":"4"}},{"id":2190626,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":847,"kind":"person","name":"ENRIGHT PATRICK G","position":1,"cik":"0001253886","reported_name":"ENRIGHT PATRICK G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2022-08-09T22:12:33.000Z","date":"2022-08-05","kind":"grant","acquired":true,"shares":2561,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These restricted stock units are granted pursuant to the Issuer's 2007 Amended and Restated Non-Employee Directors Stock Award Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. Subject to the Reporting Person's continuous service and certain additional conditions, these units will vest in full on July 28, 2023."}],"balance_after":25175,"source":{"system":"sec-edgar","filing":"0001765581-22-000084","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558122000084/edgardoc.xml","form_type":"4"}},{"id":2251432,"issuer":{"id":120922,"kind":"organization","name":"Aptinyx Inc.","symbol":"APTX"},"owners":[{"id":847,"kind":"person","name":"ENRIGHT PATRICK G","position":1,"cik":"0001253886","reported_name":"ENRIGHT PATRICK G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-05-31T16:30:48.000Z","date":"2022-05-26","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests in ratable monthly installments over one year from the date of grant."}],"balance_after":40000,"derivative":{"exercise_price":0.5,"expiration_date":"2032-05-25","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001415889-22-005905","document":"form4-05312022_040514.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674365/000141588922005905/form4-05312022_040514.xml","form_type":"4"}},{"id":2254974,"issuer":{"id":4358,"kind":"organization","name":"Vera Therapeutics, Inc.","symbol":"VERA"},"owners":[{"id":847,"kind":"person","name":"ENRIGHT PATRICK G","position":1,"cik":"0001253886","reported_name":"ENRIGHT PATRICK G","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-05-26T20:13:22.000Z","date":"2022-05-24","kind":"grant","acquired":true,"shares":9925,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest in full on the earlier of the first anniversary of the grant date or the date of the Company's 2023 annual stockholder meeting, subject to the Reporting Person's continuous service through such vesting date. Notwithstanding the foregoing, the shares will vest in full upon a change in control, subject to the Reporting Person's continuous service through the date of such change in control."}],"balance_after":9925,"derivative":{"exercise_price":16.14,"expiration_date":"2032-05-23","underlying":"Class A Common Stock","underlying_shares":9925},"source":{"system":"sec-edgar","filing":"0001209191-22-032181","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1253886/000120919122032181/doc4.xml","form_type":"4"}},{"id":2288017,"issuer":{"id":125698,"kind":"organization","name":"Sierra Oncology, Inc.","symbol":"SRRA"},"owners":[{"id":127756,"kind":"organization","name":"Longitude Capital Partners III, LLC","position":1,"cik":"0001713663","reported_name":"Longitude Capital Partners III, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":127757,"kind":"organization","name":"Longitude Venture Partners III, L.P.","position":2,"cik":"0001674099","reported_name":"Longitude Venture Partners III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36915,"kind":"person","name":"Tammenoms Bakker Juliet","position":3,"cik":"0001431159","reported_name":"Tammenoms Bakker Juliet","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":847,"kind":"person","name":"ENRIGHT PATRICK G","position":4,"cik":"0001253886","reported_name":"ENRIGHT PATRICK G","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67422,"kind":"organization","name":"Longitude Prime Partners, LLC","position":5,"cik":"0001865779","reported_name":"Longitude Prime Partners, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67423,"kind":"organization","name":"Longitude Prime Fund, L.P.","position":6,"cik":"0001865844","reported_name":"Longitude Prime Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-04-29T19:07:35.000Z","date":"2022-04-27","kind":"other","acquired":true,"shares":840,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F9","text":"Represents a pro rata distribution, and not a purchase or sale, without additional consideration by LPP to its members"},{"field":"ownership.nature","element":"natureOfOwnership","label":"F8","text":"These shares are held directly by Patrick G. Enright."}],"balance_after":8015,"source":{"system":"sec-edgar","filing":"0000899243-22-016052","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1865779/000089924322016052/doc4.xml","form_type":"4"}},{"id":2288016,"issuer":{"id":125698,"kind":"organization","name":"Sierra Oncology, Inc.","symbol":"SRRA"},"owners":[{"id":127756,"kind":"organization","name":"Longitude Capital Partners III, LLC","position":1,"cik":"0001713663","reported_name":"Longitude Capital Partners III, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":127757,"kind":"organization","name":"Longitude Venture Partners III, L.P.","position":2,"cik":"0001674099","reported_name":"Longitude Venture Partners III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36915,"kind":"person","name":"Tammenoms Bakker Juliet","position":3,"cik":"0001431159","reported_name":"Tammenoms Bakker Juliet","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":847,"kind":"person","name":"ENRIGHT PATRICK G","position":4,"cik":"0001253886","reported_name":"ENRIGHT PATRICK G","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67422,"kind":"organization","name":"Longitude Prime Partners, LLC","position":5,"cik":"0001865779","reported_name":"Longitude Prime Partners, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67423,"kind":"organization","name":"Longitude Prime Fund, L.P.","position":6,"cik":"0001865844","reported_name":"Longitude Prime Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-04-29T19:07:35.000Z","date":"2022-04-27","kind":"other","acquired":true,"shares":252,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F9","text":"Represents a pro rata distribution, and not a purchase or sale, without additional consideration by LPP to its members"},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"These shares are held by a trust. Juliet Tammenoms Bakker is the Investment Trustee of such trust and may be deemed to share voting and dispositive power with regard to the reported shares. Ms. Tammenoms Bakker disclaims beneficial ownership of such shares except to the extent of her pecuniary interest therein."}],"balance_after":2404,"source":{"system":"sec-edgar","filing":"0000899243-22-016052","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1865779/000089924322016052/doc4.xml","form_type":"4"}},{"id":2288015,"issuer":{"id":125698,"kind":"organization","name":"Sierra Oncology, Inc.","symbol":"SRRA"},"owners":[{"id":127756,"kind":"organization","name":"Longitude Capital Partners III, LLC","position":1,"cik":"0001713663","reported_name":"Longitude Capital Partners III, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":127757,"kind":"organization","name":"Longitude Venture Partners III, L.P.","position":2,"cik":"0001674099","reported_name":"Longitude Venture Partners III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36915,"kind":"person","name":"Tammenoms Bakker Juliet","position":3,"cik":"0001431159","reported_name":"Tammenoms Bakker Juliet","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":847,"kind":"person","name":"ENRIGHT PATRICK G","position":4,"cik":"0001253886","reported_name":"ENRIGHT PATRICK G","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67422,"kind":"organization","name":"Longitude Prime Partners, LLC","position":5,"cik":"0001865779","reported_name":"Longitude Prime Partners, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67423,"kind":"organization","name":"Longitude Prime Fund, L.P.","position":6,"cik":"0001865844","reported_name":"Longitude Prime Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-04-29T19:07:35.000Z","date":"2022-04-27","kind":"other","acquired":true,"shares":588,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F9","text":"Represents a pro rata distribution, and not a purchase or sale, without additional consideration by LPP to its members"},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"These shares are held directly by Juliet Tammenoms Bakker."}],"balance_after":5611,"source":{"system":"sec-edgar","filing":"0000899243-22-016052","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1865779/000089924322016052/doc4.xml","form_type":"4"}},{"id":2288014,"issuer":{"id":125698,"kind":"organization","name":"Sierra Oncology, Inc.","symbol":"SRRA"},"owners":[{"id":127756,"kind":"organization","name":"Longitude Capital Partners III, LLC","position":1,"cik":"0001713663","reported_name":"Longitude Capital Partners III, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":127757,"kind":"organization","name":"Longitude Venture Partners III, L.P.","position":2,"cik":"0001674099","reported_name":"Longitude Venture Partners III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36915,"kind":"person","name":"Tammenoms Bakker Juliet","position":3,"cik":"0001431159","reported_name":"Tammenoms Bakker Juliet","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":847,"kind":"person","name":"ENRIGHT PATRICK G","position":4,"cik":"0001253886","reported_name":"ENRIGHT PATRICK G","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67422,"kind":"organization","name":"Longitude Prime Partners, LLC","position":5,"cik":"0001865779","reported_name":"Longitude Prime Partners, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67423,"kind":"organization","name":"Longitude Prime Fund, L.P.","position":6,"cik":"0001865844","reported_name":"Longitude Prime Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-04-29T19:07:35.000Z","date":"2022-04-27","kind":"other","acquired":true,"shares":7175,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"Represents a pro rata distribution, and not a purchase or sale, without additional consideration by LCP III to its members."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F8","text":"These shares are held directly by Patrick G. Enright."}],"balance_after":7175,"source":{"system":"sec-edgar","filing":"0000899243-22-016052","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1865779/000089924322016052/doc4.xml","form_type":"4"}},{"id":2288013,"issuer":{"id":125698,"kind":"organization","name":"Sierra Oncology, Inc.","symbol":"SRRA"},"owners":[{"id":127756,"kind":"organization","name":"Longitude Capital Partners III, LLC","position":1,"cik":"0001713663","reported_name":"Longitude Capital Partners III, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":127757,"kind":"organization","name":"Longitude Venture Partners III, L.P.","position":2,"cik":"0001674099","reported_name":"Longitude Venture Partners III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36915,"kind":"person","name":"Tammenoms Bakker Juliet","position":3,"cik":"0001431159","reported_name":"Tammenoms Bakker Juliet","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":847,"kind":"person","name":"ENRIGHT PATRICK G","position":4,"cik":"0001253886","reported_name":"ENRIGHT PATRICK G","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67422,"kind":"organization","name":"Longitude Prime Partners, LLC","position":5,"cik":"0001865779","reported_name":"Longitude Prime Partners, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67423,"kind":"organization","name":"Longitude Prime Fund, L.P.","position":6,"cik":"0001865844","reported_name":"Longitude Prime Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-04-29T19:07:35.000Z","date":"2022-04-27","kind":"other","acquired":true,"shares":2152,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"Represents a pro rata distribution, and not a purchase or sale, without additional consideration by LCP III to its members."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"These shares are held by a trust. Juliet Tammenoms Bakker is the Investment Trustee of such trust and may be deemed to share voting and dispositive power with regard to the reported shares. Ms. Tammenoms Bakker disclaims beneficial ownership of such shares except to the extent of her pecuniary interest therein."}],"balance_after":2152,"source":{"system":"sec-edgar","filing":"0000899243-22-016052","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1865779/000089924322016052/doc4.xml","form_type":"4"}},{"id":2288012,"issuer":{"id":125698,"kind":"organization","name":"Sierra Oncology, Inc.","symbol":"SRRA"},"owners":[{"id":127756,"kind":"organization","name":"Longitude Capital Partners III, LLC","position":1,"cik":"0001713663","reported_name":"Longitude Capital Partners III, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":127757,"kind":"organization","name":"Longitude Venture Partners III, L.P.","position":2,"cik":"0001674099","reported_name":"Longitude Venture Partners III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36915,"kind":"person","name":"Tammenoms Bakker Juliet","position":3,"cik":"0001431159","reported_name":"Tammenoms Bakker Juliet","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":847,"kind":"person","name":"ENRIGHT PATRICK G","position":4,"cik":"0001253886","reported_name":"ENRIGHT PATRICK G","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67422,"kind":"organization","name":"Longitude Prime Partners, LLC","position":5,"cik":"0001865779","reported_name":"Longitude Prime Partners, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67423,"kind":"organization","name":"Longitude Prime Fund, L.P.","position":6,"cik":"0001865844","reported_name":"Longitude Prime Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-04-29T19:07:35.000Z","date":"2022-04-27","kind":"other","acquired":true,"shares":5023,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"Represents a pro rata distribution, and not a purchase or sale, without additional consideration by LCP III to its members."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"These shares are held directly by Juliet Tammenoms Bakker."}],"balance_after":5023,"source":{"system":"sec-edgar","filing":"0000899243-22-016052","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1865779/000089924322016052/doc4.xml","form_type":"4"}},{"id":2288011,"issuer":{"id":125698,"kind":"organization","name":"Sierra Oncology, Inc.","symbol":"SRRA"},"owners":[{"id":127756,"kind":"organization","name":"Longitude Capital Partners III, LLC","position":1,"cik":"0001713663","reported_name":"Longitude Capital Partners III, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":127757,"kind":"organization","name":"Longitude Venture Partners III, L.P.","position":2,"cik":"0001674099","reported_name":"Longitude Venture Partners III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36915,"kind":"person","name":"Tammenoms Bakker Juliet","position":3,"cik":"0001431159","reported_name":"Tammenoms Bakker Juliet","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":847,"kind":"person","name":"ENRIGHT PATRICK G","position":4,"cik":"0001253886","reported_name":"ENRIGHT PATRICK G","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67422,"kind":"organization","name":"Longitude Prime Partners, LLC","position":5,"cik":"0001865779","reported_name":"Longitude Prime Partners, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67423,"kind":"organization","name":"Longitude Prime Fund, L.P.","position":6,"cik":"0001865844","reported_name":"Longitude Prime Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-04-29T19:07:35.000Z","date":"2022-04-27","kind":"other","acquired":false,"shares":1964771,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents a pro rata distribution, and not a purchase or sale, without additional consideration by Longitude Venture Partners III, L.P. (\"LVP III\") to its general and limited partners."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"These securities are held directly by LVP III. Longitude Capital Partners III, LLC (\"LCP III\") is the general partner of LVP III and may be deemed to have voting, investment and dispositive power with respect to such securities. Patrick G. Enright and Juliet Tammenoms Bakker are the managing members of LCP III and may be deemed to share voting, investment and dispositive power over such securities. Each of LCP III, Mr. Enright, and Ms. Tammenoms Bakker disclaim beneficial ownership over such securities except to the extent of their respective pecuniary interest therein, and the inclusion of such securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purpose."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-22-016052","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1865779/000089924322016052/doc4.xml","form_type":"4"}},{"id":2288010,"issuer":{"id":125698,"kind":"organization","name":"Sierra Oncology, Inc.","symbol":"SRRA"},"owners":[{"id":127756,"kind":"organization","name":"Longitude Capital Partners III, LLC","position":1,"cik":"0001713663","reported_name":"Longitude Capital Partners III, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":127757,"kind":"organization","name":"Longitude Venture Partners III, L.P.","position":2,"cik":"0001674099","reported_name":"Longitude Venture Partners III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36915,"kind":"person","name":"Tammenoms Bakker Juliet","position":3,"cik":"0001431159","reported_name":"Tammenoms Bakker Juliet","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":847,"kind":"person","name":"ENRIGHT PATRICK G","position":4,"cik":"0001253886","reported_name":"ENRIGHT PATRICK G","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67422,"kind":"organization","name":"Longitude Prime Partners, LLC","position":5,"cik":"0001865779","reported_name":"Longitude Prime Partners, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67423,"kind":"organization","name":"Longitude Prime Fund, L.P.","position":6,"cik":"0001865844","reported_name":"Longitude Prime Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-04-29T19:07:35.000Z","date":"2022-04-27","kind":"other","acquired":false,"shares":175000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a pro rata distribution, and not a purchase or sale, without additional consideration by Longitude Prime Fund, L.P. (\"LPF\") to its general and limited partners."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities are held directly by LPF. Longitude Prime Partners, LLC (\"LPP\"), the general partner of LPF, may be deemed to have voting and investment power with respect to the shares held by LPF. Patrick G. Enright and Juliet Tammenoms Bakker are the managing members of LPP and may be deemed to share voting, investment and dispositive power over such securities. Each of LPP, Mr. Enright and Ms. Tammenoms Bakker disclaim beneficial ownership of such shares except to the extent of their respective pecuniary interests therein, and the inclusion of such securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purpose."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-22-016052","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1865779/000089924322016052/doc4.xml","form_type":"4"}},{"id":2292811,"issuer":{"id":77717,"kind":"organization","name":"Inozyme Pharma, Inc.","symbol":"INZY"},"owners":[{"id":127756,"kind":"organization","name":"Longitude Capital Partners III, LLC","position":1,"cik":"0001713663","reported_name":"Longitude Capital Partners III, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":127757,"kind":"organization","name":"Longitude Venture Partners III, L.P.","position":2,"cik":"0001674099","reported_name":"Longitude Venture Partners III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36915,"kind":"person","name":"Tammenoms Bakker Juliet","position":3,"cik":"0001431159","reported_name":"Tammenoms Bakker Juliet","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":847,"kind":"person","name":"ENRIGHT PATRICK G","position":4,"cik":"0001253886","reported_name":"ENRIGHT PATRICK G","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-04-21T18:04:37.000Z","date":"2022-04-19","kind":"purchase","acquired":true,"shares":1355000,"price":3.69,"value":4999950.0,"ownership":{"direct":false,"nature":"By Longitude Venture Partners III, L.P."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These shares are held by Longitude Venture Partners III, L.P. (\"LVP III\"). Longitude Capital Partners III, LLC (\"LCP III\") is the general partner of LVP III and may be deemed to have voting and dispositive power over the shares held by LVP III. Patrick G. Enright and Juliet Tammenoms Bakker are managing members of LCP III and may be deemed to share voting and dispositive power with respect to the shares held by LVP III. Each of LCP III, Mr. Enright and Ms. Tammenoms Bakker disclaims beneficial ownership of such shares and this report shall not be deemed an admission that any of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein."}],"balance_after":4174379,"source":{"system":"sec-edgar","filing":"0000899243-22-015325","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1693011/000089924322015325/doc4.xml","form_type":"4"}},{"id":2303843,"issuer":{"id":4358,"kind":"organization","name":"Vera Therapeutics, Inc.","symbol":"VERA"},"owners":[{"id":847,"kind":"person","name":"ENRIGHT PATRICK G","position":1,"cik":"0001253886","reported_name":"ENRIGHT PATRICK G","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2022-04-05T11:22:45.000Z","date":"2022-02-10","kind":"purchase","acquired":true,"shares":333333,"price":15,"value":4999995.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These shares are held by Longitude Venture Partners IV, L.P (\"LVP IV\"). Longitude Capital Partners IV, LLC (\"LCP IV\") is the general partner of LVP IV and may be deemed to have voting and dispositive power over the shares held by LVP IV. Patrick G. Enright and Juliet Tammenoms Bakker are managing members of LCP IV and may be deemed to share voting and dispositive power with respect to the shares held by LVP IV. Each of LCP IV, Mr. Enright and Ms. Tammenoms Bakker disclaims beneficial ownership of such shares and this report shall not be deemed an admission that any of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein."}],"balance_after":3429927,"source":{"system":"sec-edgar","filing":"0000899243-22-013596","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1253886/000089924322013596/doc4.xml","form_type":"4"}},{"id":2417048,"issuer":{"id":125698,"kind":"organization","name":"Sierra Oncology, Inc.","symbol":"SRRA"},"owners":[{"id":127756,"kind":"organization","name":"Longitude Capital Partners III, LLC","position":1,"cik":"0001713663","reported_name":"Longitude Capital Partners III, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":127757,"kind":"organization","name":"Longitude Venture Partners III, L.P.","position":2,"cik":"0001674099","reported_name":"Longitude Venture Partners III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36915,"kind":"person","name":"Tammenoms Bakker Juliet","position":3,"cik":"0001431159","reported_name":"Tammenoms Bakker Juliet","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":847,"kind":"person","name":"ENRIGHT PATRICK G","position":4,"cik":"0001253886","reported_name":"ENRIGHT PATRICK G","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67422,"kind":"organization","name":"Longitude Prime Partners, LLC","position":5,"cik":"0001865779","reported_name":"Longitude Prime Partners, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67423,"kind":"organization","name":"Longitude Prime Fund, L.P.","position":6,"cik":"0001865844","reported_name":"Longitude Prime Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-02-02T21:25:50.000Z","date":"2022-02-02","kind":"purchase","acquired":true,"shares":175000,"price":27,"value":4725000.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The securities are held directly by Longitude Prime Fund, L.P. (\"LPF\"). Longitude Prime Partners, LLC (\"LPP\"), the general partner of LPF, may be deemed to have voting and investment power with respect to the shares held by LPF. Patrick G. Enright, Juliet Tammenoms Bakker and Joshua Richardson, a member of the Issuer's board of directors, are each members of LPF and may be deemed to share voting, investment and dispositive power over such securities. Mr. Enright and Ms. Tammenoms Bakker are the managing members of LPP. Each of Mr. Enright, Ms. Tammenoms Bakker and Dr. Richardson disclaim beneficial ownership of such shares except to the extent of their respective pecuniary interests therein, and the inclusion of such securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purpose."}],"balance_after":175000,"source":{"system":"sec-edgar","filing":"0000899243-22-004271","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1865779/000089924322004271/doc4.xml","form_type":"4"}},{"id":2424223,"issuer":{"id":125698,"kind":"organization","name":"Sierra Oncology, Inc.","symbol":"SRRA"},"owners":[{"id":127756,"kind":"organization","name":"Longitude Capital Partners III, LLC","position":1,"cik":"0001713663","reported_name":"Longitude Capital Partners III, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":127757,"kind":"organization","name":"Longitude Venture Partners III, L.P.","position":2,"cik":"0001674099","reported_name":"Longitude Venture Partners III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36915,"kind":"person","name":"Tammenoms Bakker Juliet","position":3,"cik":"0001431159","reported_name":"Tammenoms Bakker Juliet","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":847,"kind":"person","name":"ENRIGHT PATRICK G","position":4,"cik":"0001253886","reported_name":"ENRIGHT PATRICK G","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B Warrants","published_at":"2022-01-27T21:23:35.000Z","date":"2022-01-25","kind":"other","acquired":false,"shares":1477125,"price":13.2,"value":19498050.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Consists of 1,477,125 Series B Warrants held by LVP III which are exercisable for an aggregate of 487,451 shares of Common Stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These securities are held directly by Longitude Venture Partners III, L.P. (\"LVP III\"). Longitude Capital Partners III, LLC (\"LCP III\") is the general partner of LVP III and may be deemed to have voting, investment and dispositive power with respect to such securities. Patrick G. Enright, Juliet Tammenoms Bakker and Joshua Richardson, a member of the Issuer's board of directors, are each members of LCP III and may be deemed to share voting, investment and dispositive power over such securities. Mr. Enright and Ms. Tammenoms Bakker are the managing members of LCP III. Each of LCP III, Mr. Enright, Ms. Tammenoms Bakker and Joshua Richardson disclaim beneficial ownership over such securities except to the extent of their respective pecuniary interest therein, and the inclusion of such securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purpose."}],"balance_after":0,"derivative":{"exercise_price":13.2,"exercise_date":"2020-01-22","expiration_date":"2022-04-10","underlying":"Common Stock","underlying_shares":487451},"source":{"system":"sec-edgar","filing":"0000899243-22-003502","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1674099/000089924322003502/doc4.xml","form_type":"4"}},{"id":2424222,"issuer":{"id":125698,"kind":"organization","name":"Sierra Oncology, Inc.","symbol":"SRRA"},"owners":[{"id":127756,"kind":"organization","name":"Longitude Capital Partners III, LLC","position":1,"cik":"0001713663","reported_name":"Longitude Capital Partners III, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":127757,"kind":"organization","name":"Longitude Venture Partners III, L.P.","position":2,"cik":"0001674099","reported_name":"Longitude Venture Partners III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36915,"kind":"person","name":"Tammenoms Bakker Juliet","position":3,"cik":"0001431159","reported_name":"Tammenoms Bakker Juliet","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":847,"kind":"person","name":"ENRIGHT PATRICK G","position":4,"cik":"0001253886","reported_name":"ENRIGHT PATRICK G","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-01-27T21:23:35.000Z","date":"2022-01-25","kind":"other","acquired":true,"shares":487451,"price":13.2,"value":6434353.2,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These securities are held directly by Longitude Venture Partners III, L.P. (\"LVP III\"). Longitude Capital Partners III, LLC (\"LCP III\") is the general partner of LVP III and may be deemed to have voting, investment and dispositive power with respect to such securities. Patrick G. Enright, Juliet Tammenoms Bakker and Joshua Richardson, a member of the Issuer's board of directors, are each members of LCP III and may be deemed to share voting, investment and dispositive power over such securities. Mr. Enright and Ms. Tammenoms Bakker are the managing members of LCP III. Each of LCP III, Mr. Enright, Ms. Tammenoms Bakker and Joshua Richardson disclaim beneficial ownership over such securities except to the extent of their respective pecuniary interest therein, and the inclusion of such securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purpose."}],"balance_after":1964771,"source":{"system":"sec-edgar","filing":"0000899243-22-003502","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674099/000089924322003502/doc4.xml","form_type":"4"}},{"id":2594642,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":847,"kind":"person","name":"ENRIGHT PATRICK G","position":1,"cik":"0001253886","reported_name":"ENRIGHT PATRICK G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2021-08-20T23:12:14.000Z","date":"2021-08-18","kind":"grant","acquired":true,"shares":2000,"price":137.75,"value":275500.0,"ownership":{"direct":false,"nature":"by Trust"},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These shares are held by a trust (the \"Trust\"). Reporting person is the Trustee of the Trust and may be deemed to share voting, investment and dispositive power over the shares held by the Trust. Reporting person disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein and this report shall not be deemed an admission of beneficial ownership for purposes of Section 16 or for any other purpose."}],"balance_after":2000,"source":{"system":"sec-edgar","filing":"0001765581-21-000114","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558121000114/edgardoc.xml","form_type":"4"}},{"id":2619819,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":847,"kind":"person","name":"ENRIGHT PATRICK G","position":1,"cik":"0001253886","reported_name":"ENRIGHT PATRICK G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2021-08-02T22:10:54.000Z","date":"2021-07-29","kind":"grant","acquired":true,"shares":2246,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These restricted stock units are granted pursuant to the Issuer's 2007 Amended and Restated Non-Employee Directors Stock Award Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. Subject to the Reporting Person's continuous service and certain additional conditions, these units will vest in full on July 29, 2022."}],"balance_after":22614,"source":{"system":"sec-edgar","filing":"0001765581-21-000069","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558121000069/edgardoc.xml","form_type":"4"}},{"id":2629387,"issuer":{"id":6966,"kind":"organization","name":"RAPID MICRO BIOSYSTEMS, INC."},"owners":[{"id":67420,"kind":"organization","name":"Longitude Capital Partners II, LLC","position":1,"cik":"0001647491","reported_name":"Longitude Capital Partners II, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67421,"kind":"organization","name":"Longitude Venture Partners II, L.P.","position":2,"cik":"0001527510","reported_name":"Longitude Venture Partners II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67422,"kind":"organization","name":"Longitude Prime Partners, LLC","position":3,"cik":"0001865779","reported_name":"Longitude Prime Partners, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67423,"kind":"organization","name":"Longitude Prime Fund, L.P.","position":4,"cik":"0001865844","reported_name":"Longitude Prime Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":847,"kind":"person","name":"ENRIGHT PATRICK G","position":5,"cik":"0001253886","reported_name":"ENRIGHT PATRICK G","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36915,"kind":"person","name":"Tammenoms Bakker Juliet","position":6,"cik":"0001431159","reported_name":"Tammenoms Bakker Juliet","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock Warrant","published_at":"2021-07-20T21:39:44.000Z","date":"2021-07-19","kind":"exercise","acquired":true,"shares":129032,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Held by Longitude Venture Partners II, L.P."},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Immediately exercisable."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The securities are held directly by Longitude Venture Partners II, L.P. (\"LVP II\"). Longitude Capital Partners II, LLC, (\"LCP II\"), the general partner of LVP II, may be deemed to have voting and investment power with respect to the shares held by LVP II. Patrick G. Enright and Juliet Tammenoms Bakker are the managing members of LCP II and may be deemed to share voting and investment power over the shares held by LVP II. Each of LCP II, Mr. Enright and Ms. Tammenoms Bakker disclaim beneficial ownership of such securities and this report shall not be deemed an admission that any one of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interest therein."}],"balance_after":129032,"derivative":{"exercise_price":0.05,"expiration_date":"2028-01-17","underlying":"Class A Common Stock","underlying_shares":129032},"source":{"system":"sec-edgar","filing":"0000899243-21-029105","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1865779/000089924321029105/doc4.xml","form_type":"4"}},{"id":2629386,"issuer":{"id":6966,"kind":"organization","name":"RAPID MICRO BIOSYSTEMS, INC."},"owners":[{"id":67420,"kind":"organization","name":"Longitude Capital Partners II, LLC","position":1,"cik":"0001647491","reported_name":"Longitude Capital Partners II, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67421,"kind":"organization","name":"Longitude Venture Partners II, L.P.","position":2,"cik":"0001527510","reported_name":"Longitude Venture Partners II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67422,"kind":"organization","name":"Longitude Prime Partners, LLC","position":3,"cik":"0001865779","reported_name":"Longitude Prime Partners, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67423,"kind":"organization","name":"Longitude Prime Fund, L.P.","position":4,"cik":"0001865844","reported_name":"Longitude Prime Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":847,"kind":"person","name":"ENRIGHT PATRICK G","position":5,"cik":"0001253886","reported_name":"ENRIGHT PATRICK G","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36915,"kind":"person","name":"Tammenoms Bakker Juliet","position":6,"cik":"0001431159","reported_name":"Tammenoms Bakker Juliet","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B1 Warrant","published_at":"2021-07-20T21:39:44.000Z","date":"2021-07-19","kind":"exercise","acquired":false,"shares":645160,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Held by Longitude Venture Partners II, L.P."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"The Issuer's Preferred Stock warrants automatically converted into warrants to purchase Common Stock immediately prior to the closing of the Issuer's initial public offering without payment or further consideration. The transaction is listed solely for the purpose of reporting the change in the shares underlying the warrants."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The Issuer's Preferred Stock warrants automatically converted into warrants to purchase Common Stock immediately prior to the closing of the Issuer's initial public offering without payment or further consideration. The transaction is listed solely for the purpose of reporting the change in the shares underlying the warrants."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The securities are held directly by Longitude Venture Partners II, L.P. (\"LVP II\"). Longitude Capital Partners II, LLC, (\"LCP II\"), the general partner of LVP II, may be deemed to have voting and investment power with respect to the shares held by LVP II. Patrick G. Enright and Juliet Tammenoms Bakker are the managing members of LCP II and may be deemed to share voting and investment power over the shares held by LVP II. Each of LCP II, Mr. Enright and Ms. Tammenoms Bakker disclaim beneficial ownership of such securities and this report shall not be deemed an admission that any one of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interest therein."}],"balance_after":0,"derivative":{"exercise_price":0.01,"expiration_date":"2028-01-17","underlying":"Series B1 Preferred Stock","underlying_shares":645160},"source":{"system":"sec-edgar","filing":"0000899243-21-029105","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1865779/000089924321029105/doc4.xml","form_type":"4"}},{"id":2629385,"issuer":{"id":6966,"kind":"organization","name":"RAPID MICRO BIOSYSTEMS, INC."},"owners":[{"id":67420,"kind":"organization","name":"Longitude Capital Partners II, LLC","position":1,"cik":"0001647491","reported_name":"Longitude Capital Partners II, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67421,"kind":"organization","name":"Longitude Venture Partners II, L.P.","position":2,"cik":"0001527510","reported_name":"Longitude Venture Partners II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67422,"kind":"organization","name":"Longitude Prime Partners, LLC","position":3,"cik":"0001865779","reported_name":"Longitude Prime Partners, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67423,"kind":"organization","name":"Longitude Prime Fund, L.P.","position":4,"cik":"0001865844","reported_name":"Longitude Prime Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":847,"kind":"person","name":"ENRIGHT PATRICK G","position":5,"cik":"0001253886","reported_name":"ENRIGHT PATRICK G","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36915,"kind":"person","name":"Tammenoms Bakker Juliet","position":6,"cik":"0001431159","reported_name":"Tammenoms Bakker Juliet","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock Warrant","published_at":"2021-07-20T21:39:44.000Z","date":"2021-07-19","kind":"exercise","acquired":true,"shares":500000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Held by Longitude Venture Partners II, L.P."},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Immediately exercisable."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The securities are held directly by Longitude Venture Partners II, L.P. (\"LVP II\"). Longitude Capital Partners II, LLC, (\"LCP II\"), the general partner of LVP II, may be deemed to have voting and investment power with respect to the shares held by LVP II. Patrick G. Enright and Juliet Tammenoms Bakker are the managing members of LCP II and may be deemed to share voting and investment power over the shares held by LVP II. Each of LCP II, Mr. Enright and Ms. Tammenoms Bakker disclaim beneficial ownership of such securities and this report shall not be deemed an admission that any one of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interest therein."}],"balance_after":500000,"derivative":{"exercise_price":0.05,"expiration_date":"2027-07-24","underlying":"Class A Common Stock","underlying_shares":500000},"source":{"system":"sec-edgar","filing":"0000899243-21-029105","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1865779/000089924321029105/doc4.xml","form_type":"4"}},{"id":2629384,"issuer":{"id":6966,"kind":"organization","name":"RAPID MICRO BIOSYSTEMS, INC."},"owners":[{"id":67420,"kind":"organization","name":"Longitude Capital Partners II, LLC","position":1,"cik":"0001647491","reported_name":"Longitude Capital Partners II, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67421,"kind":"organization","name":"Longitude Venture Partners II, L.P.","position":2,"cik":"0001527510","reported_name":"Longitude Venture Partners II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67422,"kind":"organization","name":"Longitude Prime Partners, LLC","position":3,"cik":"0001865779","reported_name":"Longitude Prime Partners, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67423,"kind":"organization","name":"Longitude Prime Fund, L.P.","position":4,"cik":"0001865844","reported_name":"Longitude Prime Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":847,"kind":"person","name":"ENRIGHT PATRICK G","position":5,"cik":"0001253886","reported_name":"ENRIGHT PATRICK G","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36915,"kind":"person","name":"Tammenoms Bakker Juliet","position":6,"cik":"0001431159","reported_name":"Tammenoms Bakker Juliet","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A1 Warrant","published_at":"2021-07-20T21:39:44.000Z","date":"2021-07-19","kind":"exercise","acquired":false,"shares":2500000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Held by Longitude Venture Partners II, L.P."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"The Issuer's Preferred Stock warrants automatically converted into warrants to purchase Common Stock immediately prior to the closing of the Issuer's initial public offering without payment or further consideration. The transaction is listed solely for the purpose of reporting the change in the shares underlying the warrants."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The Issuer's Preferred Stock warrants automatically converted into warrants to purchase Common Stock immediately prior to the closing of the Issuer's initial public offering without payment or further consideration. The transaction is listed solely for the purpose of reporting the change in the shares underlying the warrants."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The securities are held directly by Longitude Venture Partners II, L.P. (\"LVP II\"). Longitude Capital Partners II, LLC, (\"LCP II\"), the general partner of LVP II, may be deemed to have voting and investment power with respect to the shares held by LVP II. Patrick G. Enright and Juliet Tammenoms Bakker are the managing members of LCP II and may be deemed to share voting and investment power over the shares held by LVP II. Each of LCP II, Mr. Enright and Ms. Tammenoms Bakker disclaim beneficial ownership of such securities and this report shall not be deemed an admission that any one of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interest therein."}],"balance_after":0,"derivative":{"exercise_price":0.01,"expiration_date":"2027-07-24","underlying":"Series A1 Preferred Stock","underlying_shares":2500000},"source":{"system":"sec-edgar","filing":"0000899243-21-029105","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1865779/000089924321029105/doc4.xml","form_type":"4"}},{"id":2629383,"issuer":{"id":6966,"kind":"organization","name":"RAPID MICRO BIOSYSTEMS, INC."},"owners":[{"id":67420,"kind":"organization","name":"Longitude Capital Partners II, LLC","position":1,"cik":"0001647491","reported_name":"Longitude Capital Partners II, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67421,"kind":"organization","name":"Longitude Venture Partners II, L.P.","position":2,"cik":"0001527510","reported_name":"Longitude Venture Partners II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67422,"kind":"organization","name":"Longitude Prime Partners, LLC","position":3,"cik":"0001865779","reported_name":"Longitude Prime Partners, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67423,"kind":"organization","name":"Longitude Prime Fund, L.P.","position":4,"cik":"0001865844","reported_name":"Longitude Prime Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":847,"kind":"person","name":"ENRIGHT PATRICK G","position":5,"cik":"0001253886","reported_name":"ENRIGHT PATRICK G","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36915,"kind":"person","name":"Tammenoms Bakker Juliet","position":6,"cik":"0001431159","reported_name":"Tammenoms Bakker Juliet","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series C1 Preferred Stock","published_at":"2021-07-20T21:39:44.000Z","date":"2021-07-19","kind":"exercise","acquired":false,"shares":2291665,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Held by Longitude Venture Partners II, L.P."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"The Series A1 Preferred Stock, Series B1 Preferred Stock and Series C1 Preferred Stock (collectively, the \"Preferred Stock\") are convertible at any time, at the holder's election and have no expiration date.  Each share of Preferred Stock automatically converted into 0.20 shares of the Issuer's Class A Common Stock upon the closing of the Issuer's initial public offering."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The Series A1 Preferred Stock, Series B1 Preferred Stock and Series C1 Preferred Stock (collectively, the \"Preferred Stock\") are convertible at any time, at the holder's election and have no expiration date.  Each share of Preferred Stock automatically converted into 0.20 shares of the Issuer's Class A Common Stock upon the closing of the Issuer's initial public offering."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The Series A1 Preferred Stock, Series B1 Preferred Stock and Series C1 Preferred Stock (collectively, the \"Preferred Stock\") are convertible at any time, at the holder's election and have no expiration date.  Each share of Preferred Stock automatically converted into 0.20 shares of the Issuer's Class A Common Stock upon the closing of the Issuer's initial public offering."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The securities are held directly by Longitude Venture Partners II, L.P. (\"LVP II\"). Longitude Capital Partners II, LLC, (\"LCP II\"), the general partner of LVP II, may be deemed to have voting and investment power with respect to the shares held by LVP II. Patrick G. Enright and Juliet Tammenoms Bakker are the managing members of LCP II and may be deemed to share voting and investment power over the shares held by LVP II. Each of LCP II, Mr. Enright and Ms. Tammenoms Bakker disclaim beneficial ownership of such securities and this report shall not be deemed an admission that any one of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":458333},"source":{"system":"sec-edgar","filing":"0000899243-21-029105","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1865779/000089924321029105/doc4.xml","form_type":"4"}},{"id":2629382,"issuer":{"id":6966,"kind":"organization","name":"RAPID MICRO BIOSYSTEMS, INC."},"owners":[{"id":67420,"kind":"organization","name":"Longitude Capital Partners II, LLC","position":1,"cik":"0001647491","reported_name":"Longitude Capital Partners II, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67421,"kind":"organization","name":"Longitude Venture Partners II, L.P.","position":2,"cik":"0001527510","reported_name":"Longitude Venture Partners II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67422,"kind":"organization","name":"Longitude Prime Partners, LLC","position":3,"cik":"0001865779","reported_name":"Longitude Prime Partners, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67423,"kind":"organization","name":"Longitude Prime Fund, L.P.","position":4,"cik":"0001865844","reported_name":"Longitude Prime Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":847,"kind":"person","name":"ENRIGHT PATRICK G","position":5,"cik":"0001253886","reported_name":"ENRIGHT PATRICK G","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36915,"kind":"person","name":"Tammenoms Bakker Juliet","position":6,"cik":"0001431159","reported_name":"Tammenoms Bakker Juliet","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B1 Preferred Stock","published_at":"2021-07-20T21:39:44.000Z","date":"2021-07-19","kind":"exercise","acquired":false,"shares":5654529,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Held by Longitude Venture Partners II, L.P."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"The Series A1 Preferred Stock, Series B1 Preferred Stock and Series C1 Preferred Stock (collectively, the \"Preferred Stock\") are convertible at any time, at the holder's election and have no expiration date.  Each share of Preferred Stock automatically converted into 0.20 shares of the Issuer's Class A Common Stock upon the closing of the Issuer's initial public offering."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The Series A1 Preferred Stock, Series B1 Preferred Stock and Series C1 Preferred Stock (collectively, the \"Preferred Stock\") are convertible at any time, at the holder's election and have no expiration date.  Each share of Preferred Stock automatically converted into 0.20 shares of the Issuer's Class A Common Stock upon the closing of the Issuer's initial public offering."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The Series A1 Preferred Stock, Series B1 Preferred Stock and Series C1 Preferred Stock (collectively, the \"Preferred Stock\") are convertible at any time, at the holder's election and have no expiration date.  Each share of Preferred Stock automatically converted into 0.20 shares of the Issuer's Class A Common Stock upon the closing of the Issuer's initial public offering."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The securities are held directly by Longitude Venture Partners II, L.P. (\"LVP II\"). Longitude Capital Partners II, LLC, (\"LCP II\"), the general partner of LVP II, may be deemed to have voting and investment power with respect to the shares held by LVP II. Patrick G. Enright and Juliet Tammenoms Bakker are the managing members of LCP II and may be deemed to share voting and investment power over the shares held by LVP II. Each of LCP II, Mr. Enright and Ms. Tammenoms Bakker disclaim beneficial ownership of such securities and this report shall not be deemed an admission that any one of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":1130904},"source":{"system":"sec-edgar","filing":"0000899243-21-029105","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1865779/000089924321029105/doc4.xml","form_type":"4"}},{"id":2629381,"issuer":{"id":6966,"kind":"organization","name":"RAPID MICRO BIOSYSTEMS, INC."},"owners":[{"id":67420,"kind":"organization","name":"Longitude Capital Partners II, LLC","position":1,"cik":"0001647491","reported_name":"Longitude Capital Partners II, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67421,"kind":"organization","name":"Longitude Venture Partners II, L.P.","position":2,"cik":"0001527510","reported_name":"Longitude Venture Partners II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67422,"kind":"organization","name":"Longitude Prime Partners, LLC","position":3,"cik":"0001865779","reported_name":"Longitude Prime Partners, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67423,"kind":"organization","name":"Longitude Prime Fund, L.P.","position":4,"cik":"0001865844","reported_name":"Longitude Prime Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":847,"kind":"person","name":"ENRIGHT PATRICK G","position":5,"cik":"0001253886","reported_name":"ENRIGHT PATRICK G","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36915,"kind":"person","name":"Tammenoms Bakker Juliet","position":6,"cik":"0001431159","reported_name":"Tammenoms Bakker Juliet","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A1 Preferred Stock","published_at":"2021-07-20T21:39:44.000Z","date":"2021-07-19","kind":"exercise","acquired":false,"shares":8774007,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Held by Longitude Venture Partners II, L.P."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"The Series A1 Preferred Stock, Series B1 Preferred Stock and Series C1 Preferred Stock (collectively, the \"Preferred Stock\") are convertible at any time, at the holder's election and have no expiration date.  Each share of Preferred Stock automatically converted into 0.20 shares of the Issuer's Class A Common Stock upon the closing of the Issuer's initial public offering."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The Series A1 Preferred Stock, Series B1 Preferred Stock and Series C1 Preferred Stock (collectively, the \"Preferred Stock\") are convertible at any time, at the holder's election and have no expiration date.  Each share of Preferred Stock automatically converted into 0.20 shares of the Issuer's Class A Common Stock upon the closing of the Issuer's initial public offering."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The Series A1 Preferred Stock, Series B1 Preferred Stock and Series C1 Preferred Stock (collectively, the \"Preferred Stock\") are convertible at any time, at the holder's election and have no expiration date.  Each share of Preferred Stock automatically converted into 0.20 shares of the Issuer's Class A Common Stock upon the closing of the Issuer's initial public offering."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The securities are held directly by Longitude Venture Partners II, L.P. (\"LVP II\"). Longitude Capital Partners II, LLC, (\"LCP II\"), the general partner of LVP II, may be deemed to have voting and investment power with respect to the shares held by LVP II. Patrick G. Enright and Juliet Tammenoms Bakker are the managing members of LCP II and may be deemed to share voting and investment power over the shares held by LVP II. Each of LCP II, Mr. Enright and Ms. Tammenoms Bakker disclaim beneficial ownership of such securities and this report shall not be deemed an admission that any one of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":1754801},"source":{"system":"sec-edgar","filing":"0000899243-21-029105","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1865779/000089924321029105/doc4.xml","form_type":"4"}},{"id":2629380,"issuer":{"id":6966,"kind":"organization","name":"RAPID MICRO BIOSYSTEMS, INC."},"owners":[{"id":67420,"kind":"organization","name":"Longitude Capital Partners II, LLC","position":1,"cik":"0001647491","reported_name":"Longitude Capital Partners II, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67421,"kind":"organization","name":"Longitude Venture Partners II, L.P.","position":2,"cik":"0001527510","reported_name":"Longitude Venture Partners II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67422,"kind":"organization","name":"Longitude Prime Partners, LLC","position":3,"cik":"0001865779","reported_name":"Longitude Prime Partners, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67423,"kind":"organization","name":"Longitude Prime Fund, L.P.","position":4,"cik":"0001865844","reported_name":"Longitude Prime Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":847,"kind":"person","name":"ENRIGHT PATRICK G","position":5,"cik":"0001253886","reported_name":"ENRIGHT PATRICK G","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36915,"kind":"person","name":"Tammenoms Bakker Juliet","position":6,"cik":"0001431159","reported_name":"Tammenoms Bakker Juliet","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2021-07-20T21:39:44.000Z","date":"2021-07-19","kind":"purchase","acquired":true,"shares":150000,"price":20,"value":3000000.0,"ownership":{"direct":false,"nature":"Held by Longitude Prime Fund, L.P."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities are held directly by Longitude Prime Fund, L.P. (\"LPF\"). Longitude Prime Partners, LLC (\"LPP\"), the general partner of LPF, may be deemed to have voting and investment power with respect to the shares held by LPF. Mr. Enright and Ms. Tammenoms Bakker are the managing members of LPP and may be deemed to have voting, investment and dispositive power over the shares held by LPF.  LPP and each of Mr. Enright and Ms. Tammenoms Bakker disclaim beneficial ownership of such shares except to the extent of their respective pecuniary interests therein."}],"balance_after":150000,"source":{"system":"sec-edgar","filing":"0000899243-21-029105","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1865779/000089924321029105/doc4.xml","form_type":"4"}},{"id":2629379,"issuer":{"id":6966,"kind":"organization","name":"RAPID MICRO BIOSYSTEMS, INC."},"owners":[{"id":67420,"kind":"organization","name":"Longitude Capital Partners II, LLC","position":1,"cik":"0001647491","reported_name":"Longitude Capital Partners II, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67421,"kind":"organization","name":"Longitude Venture Partners II, L.P.","position":2,"cik":"0001527510","reported_name":"Longitude Venture Partners II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67422,"kind":"organization","name":"Longitude Prime Partners, LLC","position":3,"cik":"0001865779","reported_name":"Longitude Prime Partners, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67423,"kind":"organization","name":"Longitude Prime Fund, L.P.","position":4,"cik":"0001865844","reported_name":"Longitude Prime Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":847,"kind":"person","name":"ENRIGHT PATRICK G","position":5,"cik":"0001253886","reported_name":"ENRIGHT PATRICK G","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36915,"kind":"person","name":"Tammenoms Bakker Juliet","position":6,"cik":"0001431159","reported_name":"Tammenoms Bakker Juliet","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2021-07-20T21:39:44.000Z","date":"2021-07-19","kind":"exercise","acquired":true,"shares":3344038,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Held by Longitude Venture Partners II, L.P."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The securities are held directly by Longitude Venture Partners II, L.P. (\"LVP II\"). Longitude Capital Partners II, LLC, (\"LCP II\"), the general partner of LVP II, may be deemed to have voting and investment power with respect to the shares held by LVP II. Patrick G. Enright and Juliet Tammenoms Bakker are the managing members of LCP II and may be deemed to share voting and investment power over the shares held by LVP II. Each of LCP II, Mr. Enright and Ms. Tammenoms Bakker disclaim beneficial ownership of such securities and this report shall not be deemed an admission that any one of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interest therein."}],"balance_after":3407952,"source":{"system":"sec-edgar","filing":"0000899243-21-029105","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1865779/000089924321029105/doc4.xml","form_type":"4"}},{"id":2689024,"issuer":{"id":120922,"kind":"organization","name":"Aptinyx Inc.","symbol":"APTX"},"owners":[{"id":847,"kind":"person","name":"ENRIGHT PATRICK G","position":1,"cik":"0001253886","reported_name":"ENRIGHT PATRICK G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-01T16:31:32.000Z","date":"2021-05-27","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests in ratable monthly installments over one year from the date of grant."}],"balance_after":40000,"derivative":{"exercise_price":2.59,"expiration_date":"2031-05-26","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001415889-21-002734","document":"form4-06012021_010612.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674365/000141588921002734/form4-06012021_010612.xml","form_type":"4"}},{"id":2707505,"issuer":{"id":4358,"kind":"organization","name":"Vera Therapeutics, Inc.","symbol":"VERA"},"owners":[{"id":847,"kind":"person","name":"ENRIGHT PATRICK G","position":1,"cik":"0001253886","reported_name":"ENRIGHT PATRICK G","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series C Preferred Stock","published_at":"2021-05-19T00:14:02.000Z","date":"2021-05-18","kind":"exercise","acquired":false,"shares":2187504,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Series C Preferred Stock automatically converted into Class A Common Stock on a 11.5869:1 basis (on an adjusted basis, after giving effect to the reverse stock split of the Class A Common Stock effected by the Issuer on May 7, 2021) and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Series C Preferred Stock automatically converted into Class A Common Stock on a 11.5869:1 basis (on an adjusted basis, after giving effect to the reverse stock split of the Class A Common Stock effected by the Issuer on May 7, 2021) and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Series C Preferred Stock automatically converted into Class A Common Stock on a 11.5869:1 basis (on an adjusted basis, after giving effect to the reverse stock split of the Class A Common Stock effected by the Issuer on May 7, 2021) and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held by Longitude Venture Partners IV, L.P (\"LVP IV\"). Longitude Capital Partners IV, LLC (\"LCP IV\") is the general partner of LVP IV and may be deemed to have voting and dispositive power over the shares held by LVP IV. Patrick G. Enright and Juliet Tammenoms Bakker are managing members of LCP IV and may be deemed to share voting and dispositive power with respect to the shares held by LVP IV. Each of LCP IV, Mr. Enright and Ms. Tammenoms Bakker disclaims beneficial ownership of such shares and this report shall not be deemed an admission that any of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":2187504},"source":{"system":"sec-edgar","filing":"0001209191-21-033809","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1253886/000120919121033809/doc4.xml","form_type":"4"}},{"id":2707504,"issuer":{"id":4358,"kind":"organization","name":"Vera Therapeutics, Inc.","symbol":"VERA"},"owners":[{"id":847,"kind":"person","name":"ENRIGHT PATRICK G","position":1,"cik":"0001253886","reported_name":"ENRIGHT PATRICK G","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2021-05-19T00:14:02.000Z","date":"2021-05-18","kind":"purchase","acquired":true,"shares":909090,"price":11,"value":9999990.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held by Longitude Venture Partners IV, L.P (\"LVP IV\"). Longitude Capital Partners IV, LLC (\"LCP IV\") is the general partner of LVP IV and may be deemed to have voting and dispositive power over the shares held by LVP IV. Patrick G. Enright and Juliet Tammenoms Bakker are managing members of LCP IV and may be deemed to share voting and dispositive power with respect to the shares held by LVP IV. Each of LCP IV, Mr. Enright and Ms. Tammenoms Bakker disclaims beneficial ownership of such shares and this report shall not be deemed an admission that any of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein."}],"balance_after":3096594,"source":{"system":"sec-edgar","filing":"0001209191-21-033809","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1253886/000120919121033809/doc4.xml","form_type":"4"}},{"id":2707503,"issuer":{"id":4358,"kind":"organization","name":"Vera Therapeutics, Inc.","symbol":"VERA"},"owners":[{"id":847,"kind":"person","name":"ENRIGHT PATRICK G","position":1,"cik":"0001253886","reported_name":"ENRIGHT PATRICK G","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2021-05-19T00:14:02.000Z","date":"2021-05-18","kind":"exercise","acquired":true,"shares":2187504,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Series C Preferred Stock automatically converted into Class A Common Stock on a 11.5869:1 basis (on an adjusted basis, after giving effect to the reverse stock split of the Class A Common Stock effected by the Issuer on May 7, 2021) and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held by Longitude Venture Partners IV, L.P (\"LVP IV\"). Longitude Capital Partners IV, LLC (\"LCP IV\") is the general partner of LVP IV and may be deemed to have voting and dispositive power over the shares held by LVP IV. Patrick G. Enright and Juliet Tammenoms Bakker are managing members of LCP IV and may be deemed to share voting and dispositive power with respect to the shares held by LVP IV. Each of LCP IV, Mr. Enright and Ms. Tammenoms Bakker disclaims beneficial ownership of such shares and this report shall not be deemed an admission that any of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein."}],"balance_after":2187504,"source":{"system":"sec-edgar","filing":"0001209191-21-033809","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1253886/000120919121033809/doc4.xml","form_type":"4"}},{"id":2710050,"issuer":{"id":4358,"kind":"organization","name":"Vera Therapeutics, Inc.","symbol":"VERA"},"owners":[{"id":847,"kind":"person","name":"ENRIGHT PATRICK G","position":1,"cik":"0001253886","reported_name":"ENRIGHT PATRICK G","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-05-18T00:36:56.000Z","date":"2021-05-13","kind":"grant","acquired":true,"shares":9925,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest on the earlier of May 13, 2022 or the 2022 annual meeting of stockholders."}],"balance_after":9925,"derivative":{"exercise_price":11,"expiration_date":"2031-05-12","underlying":"Class A Common Stock","underlying_shares":9925},"source":{"system":"sec-edgar","filing":"0001209191-21-033340","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1253886/000120919121033340/doc4.xml","form_type":"4"}},{"id":2718657,"issuer":{"id":15643,"kind":"organization","name":"Tourmaline Bio, Inc.","symbol":"TRML"},"owners":[{"id":127756,"kind":"organization","name":"Longitude Capital Partners III, LLC","position":1,"cik":"0001713663","reported_name":"Longitude Capital Partners III, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":127757,"kind":"organization","name":"Longitude Venture Partners III, L.P.","position":2,"cik":"0001674099","reported_name":"Longitude Venture Partners III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":847,"kind":"person","name":"ENRIGHT PATRICK G","position":3,"cik":"0001253886","reported_name":"ENRIGHT PATRICK G","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36915,"kind":"person","name":"Tammenoms Bakker Juliet","position":4,"cik":"0001431159","reported_name":"Tammenoms Bakker Juliet","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B Preferred Stock","published_at":"2021-05-11T20:29:16.000Z","date":"2021-05-11","kind":"exercise","acquired":false,"shares":406338,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Longitude Venture Partners III, L.P."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series A Preferred Stock converted into common stock on a 1-for-5.35 basis automatically upon the closing of the Issuer's initial public offering. Each share of Series A-1 Preferred Stock converted into common stock on a 1-for-5.35 basis automatically upon the closing of the Issuer's initial public offering. Each share of Series B Preferred Stock converted into common stock on a 1-for-5.35 basis automatically upon the closing of the Issuer's initial public offering. The Series A Preferred Stock, Series A-1 Preferred Stock and Series B Preferred Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series A Preferred Stock converted into common stock on a 1-for-5.35 basis automatically upon the closing of the Issuer's initial public offering. Each share of Series A-1 Preferred Stock converted into common stock on a 1-for-5.35 basis automatically upon the closing of the Issuer's initial public offering. Each share of Series B Preferred Stock converted into common stock on a 1-for-5.35 basis automatically upon the closing of the Issuer's initial public offering. The Series A Preferred Stock, Series A-1 Preferred Stock and Series B Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series A Preferred Stock converted into common stock on a 1-for-5.35 basis automatically upon the closing of the Issuer's initial public offering. Each share of Series A-1 Preferred Stock converted into common stock on a 1-for-5.35 basis automatically upon the closing of the Issuer's initial public offering. Each share of Series B Preferred Stock converted into common stock on a 1-for-5.35 basis automatically upon the closing of the Issuer's initial public offering. The Series A Preferred Stock, Series A-1 Preferred Stock and Series B Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held by Longitude Venture Partners III, L.P (\"LVP III\"). Longitude Capital Partners III, LLC (\"LCP III\") is the general partner of LVP III and may be deemed to have voting and investment power over the shares held by LVP III. Patrick G. Enright and Juliet Tammenoms Bakker are managing members of LCP III and may be deemed to share voting and investment power with respect to the shares held by LVP III. Each of LCP III, Mr. Enright and Ms. Tammenoms Bakker disclaims beneficial ownership of such shares and this report shall not be deemed an admission that any of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":406338},"source":{"system":"sec-edgar","filing":"0000899243-21-019166","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1674099/000089924321019166/doc4.xml","form_type":"4"}},{"id":2718656,"issuer":{"id":15643,"kind":"organization","name":"Tourmaline Bio, Inc.","symbol":"TRML"},"owners":[{"id":127756,"kind":"organization","name":"Longitude Capital Partners III, LLC","position":1,"cik":"0001713663","reported_name":"Longitude Capital Partners III, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":127757,"kind":"organization","name":"Longitude Venture Partners III, L.P.","position":2,"cik":"0001674099","reported_name":"Longitude Venture Partners III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":847,"kind":"person","name":"ENRIGHT PATRICK G","position":3,"cik":"0001253886","reported_name":"ENRIGHT PATRICK G","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36915,"kind":"person","name":"Tammenoms Bakker Juliet","position":4,"cik":"0001431159","reported_name":"Tammenoms Bakker Juliet","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A-1 Preferred Stock","published_at":"2021-05-11T20:29:16.000Z","date":"2021-05-11","kind":"exercise","acquired":false,"shares":1271027,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Longitude Venture Partners III, L.P."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series A Preferred Stock converted into common stock on a 1-for-5.35 basis automatically upon the closing of the Issuer's initial public offering. Each share of Series A-1 Preferred Stock converted into common stock on a 1-for-5.35 basis automatically upon the closing of the Issuer's initial public offering. Each share of Series B Preferred Stock converted into common stock on a 1-for-5.35 basis automatically upon the closing of the Issuer's initial public offering. The Series A Preferred Stock, Series A-1 Preferred Stock and Series B Preferred Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series A Preferred Stock converted into common stock on a 1-for-5.35 basis automatically upon the closing of the Issuer's initial public offering. Each share of Series A-1 Preferred Stock converted into common stock on a 1-for-5.35 basis automatically upon the closing of the Issuer's initial public offering. Each share of Series B Preferred Stock converted into common stock on a 1-for-5.35 basis automatically upon the closing of the Issuer's initial public offering. The Series A Preferred Stock, Series A-1 Preferred Stock and Series B Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series A Preferred Stock converted into common stock on a 1-for-5.35 basis automatically upon the closing of the Issuer's initial public offering. Each share of Series A-1 Preferred Stock converted into common stock on a 1-for-5.35 basis automatically upon the closing of the Issuer's initial public offering. Each share of Series B Preferred Stock converted into common stock on a 1-for-5.35 basis automatically upon the closing of the Issuer's initial public offering. The Series A Preferred Stock, Series A-1 Preferred Stock and Series B Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held by Longitude Venture Partners III, L.P (\"LVP III\"). Longitude Capital Partners III, LLC (\"LCP III\") is the general partner of LVP III and may be deemed to have voting and investment power over the shares held by LVP III. Patrick G. Enright and Juliet Tammenoms Bakker are managing members of LCP III and may be deemed to share voting and investment power with respect to the shares held by LVP III. Each of LCP III, Mr. Enright and Ms. Tammenoms Bakker disclaims beneficial ownership of such shares and this report shall not be deemed an admission that any of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1271027},"source":{"system":"sec-edgar","filing":"0000899243-21-019166","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1674099/000089924321019166/doc4.xml","form_type":"4"}},{"id":2718655,"issuer":{"id":15643,"kind":"organization","name":"Tourmaline Bio, Inc.","symbol":"TRML"},"owners":[{"id":127756,"kind":"organization","name":"Longitude Capital Partners III, LLC","position":1,"cik":"0001713663","reported_name":"Longitude Capital Partners III, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":127757,"kind":"organization","name":"Longitude Venture Partners III, L.P.","position":2,"cik":"0001674099","reported_name":"Longitude Venture Partners III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":847,"kind":"person","name":"ENRIGHT PATRICK G","position":3,"cik":"0001253886","reported_name":"ENRIGHT PATRICK G","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36915,"kind":"person","name":"Tammenoms Bakker Juliet","position":4,"cik":"0001431159","reported_name":"Tammenoms Bakker Juliet","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A Preferred Stock","published_at":"2021-05-11T20:29:16.000Z","date":"2021-05-11","kind":"exercise","acquired":false,"shares":1308410,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Longitude Venture Partners III, L.P."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series A Preferred Stock converted into common stock on a 1-for-5.35 basis automatically upon the closing of the Issuer's initial public offering. Each share of Series A-1 Preferred Stock converted into common stock on a 1-for-5.35 basis automatically upon the closing of the Issuer's initial public offering. Each share of Series B Preferred Stock converted into common stock on a 1-for-5.35 basis automatically upon the closing of the Issuer's initial public offering. The Series A Preferred Stock, Series A-1 Preferred Stock and Series B Preferred Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series A Preferred Stock converted into common stock on a 1-for-5.35 basis automatically upon the closing of the Issuer's initial public offering. Each share of Series A-1 Preferred Stock converted into common stock on a 1-for-5.35 basis automatically upon the closing of the Issuer's initial public offering. Each share of Series B Preferred Stock converted into common stock on a 1-for-5.35 basis automatically upon the closing of the Issuer's initial public offering. The Series A Preferred Stock, Series A-1 Preferred Stock and Series B Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series A Preferred Stock converted into common stock on a 1-for-5.35 basis automatically upon the closing of the Issuer's initial public offering. Each share of Series A-1 Preferred Stock converted into common stock on a 1-for-5.35 basis automatically upon the closing of the Issuer's initial public offering. Each share of Series B Preferred Stock converted into common stock on a 1-for-5.35 basis automatically upon the closing of the Issuer's initial public offering. The Series A Preferred Stock, Series A-1 Preferred Stock and Series B Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held by Longitude Venture Partners III, L.P (\"LVP III\"). Longitude Capital Partners III, LLC (\"LCP III\") is the general partner of LVP III and may be deemed to have voting and investment power over the shares held by LVP III. Patrick G. Enright and Juliet Tammenoms Bakker are managing members of LCP III and may be deemed to share voting and investment power with respect to the shares held by LVP III. Each of LCP III, Mr. Enright and Ms. Tammenoms Bakker disclaims beneficial ownership of such shares and this report shall not be deemed an admission that any of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1308410},"source":{"system":"sec-edgar","filing":"0000899243-21-019166","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1674099/000089924321019166/doc4.xml","form_type":"4"}},{"id":2718654,"issuer":{"id":15643,"kind":"organization","name":"Tourmaline Bio, Inc.","symbol":"TRML"},"owners":[{"id":127756,"kind":"organization","name":"Longitude Capital Partners III, LLC","position":1,"cik":"0001713663","reported_name":"Longitude Capital Partners III, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":127757,"kind":"organization","name":"Longitude Venture Partners III, L.P.","position":2,"cik":"0001674099","reported_name":"Longitude Venture Partners III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":847,"kind":"person","name":"ENRIGHT PATRICK G","position":3,"cik":"0001253886","reported_name":"ENRIGHT PATRICK G","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36915,"kind":"person","name":"Tammenoms Bakker Juliet","position":4,"cik":"0001431159","reported_name":"Tammenoms Bakker Juliet","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-05-11T20:29:16.000Z","date":"2021-05-11","kind":"purchase","acquired":true,"shares":235000,"price":17,"value":3995000.0,"ownership":{"direct":false,"nature":"By Longitude Venture Partners III, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"On May 11, 2021, LVP III purchased 235,000 shares of Common Stock of the Issuer at a price of $17.00 per share pursuant to an underwritten public offering."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held by Longitude Venture Partners III, L.P (\"LVP III\"). Longitude Capital Partners III, LLC (\"LCP III\") is the general partner of LVP III and may be deemed to have voting and investment power over the shares held by LVP III. Patrick G. Enright and Juliet Tammenoms Bakker are managing members of LCP III and may be deemed to share voting and investment power with respect to the shares held by LVP III. Each of LCP III, Mr. Enright and Ms. Tammenoms Bakker disclaims beneficial ownership of such shares and this report shall not be deemed an admission that any of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein."}],"balance_after":3220775,"source":{"system":"sec-edgar","filing":"0000899243-21-019166","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1674099/000089924321019166/doc4.xml","form_type":"4"}},{"id":2718653,"issuer":{"id":15643,"kind":"organization","name":"Tourmaline Bio, Inc.","symbol":"TRML"},"owners":[{"id":127756,"kind":"organization","name":"Longitude Capital Partners III, LLC","position":1,"cik":"0001713663","reported_name":"Longitude Capital Partners III, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":127757,"kind":"organization","name":"Longitude Venture Partners III, L.P.","position":2,"cik":"0001674099","reported_name":"Longitude Venture Partners III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":847,"kind":"person","name":"ENRIGHT PATRICK G","position":3,"cik":"0001253886","reported_name":"ENRIGHT PATRICK G","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36915,"kind":"person","name":"Tammenoms Bakker Juliet","position":4,"cik":"0001431159","reported_name":"Tammenoms Bakker Juliet","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-05-11T20:29:16.000Z","date":"2021-05-11","kind":"exercise","acquired":true,"shares":2985775,"ownership":{"direct":false,"nature":"By Longitude Venture Partners III, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series A Preferred Stock converted into common stock on a 1-for-5.35 basis automatically upon the closing of the Issuer's initial public offering. Each share of Series A-1 Preferred Stock converted into common stock on a 1-for-5.35 basis automatically upon the closing of the Issuer's initial public offering. Each share of Series B Preferred Stock converted into common stock on a 1-for-5.35 basis automatically upon the closing of the Issuer's initial public offering. The Series A Preferred Stock, Series A-1 Preferred Stock and Series B Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held by Longitude Venture Partners III, L.P (\"LVP III\"). Longitude Capital Partners III, LLC (\"LCP III\") is the general partner of LVP III and may be deemed to have voting and investment power over the shares held by LVP III. Patrick G. Enright and Juliet Tammenoms Bakker are managing members of LCP III and may be deemed to share voting and investment power with respect to the shares held by LVP III. Each of LCP III, Mr. Enright and Ms. Tammenoms Bakker disclaims beneficial ownership of such shares and this report shall not be deemed an admission that any of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein."}],"balance_after":2985775,"source":{"system":"sec-edgar","filing":"0000899243-21-019166","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674099/000089924321019166/doc4.xml","form_type":"4"}}],"next_cursor":"2021-05-11T20:29:16.000000Z,2718653"}